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ABSTRACT OF THE DISSERTATION
THE DEVELOPMENT OF A SURFACE ENHANCED RAMAN SPECTROSCOPY
METHOD FOR THE DETECTION OF SYNTHETIC CANNABINOIDS IN URINE
by
Thaddeus Mostowtt
Florida International University, 2020
Miami, Florida
Professor Bruce McCord, Major Professor
The use and abuse of synthetic cannabinoids has increased significantly in recent
years due to their easy access and growing popularity. Despite having more known drugs
become illegal, new synthetic versions of these drugs are being made that have not yet
been recognized or classified as illegal substances. Therefore, standard methods may not
be able to detect these drugs.
The most common method of screening detection for drugs of abuse in biological
samples is the immunoassay. However, the immunoassay method presents some
disadvantages, particularly for newly synthesized compounds. More advanced methods
have also been used, such as LC-MS; however, these procedures involve complex sample
preparation and long run times.
A potential solution to this issue is surface enhanced Raman spectroscopy
(SERS). When Raman spectroscopy is performed in the presence of metallic
nanoparticles and aggregating agents, the signal can be enhanced several orders of
magnitude via the creation hot-spots that results from displacement of the stabilizing
agent, which leads to a change in the surface charge of the metallic nanoparticle and the

vi

ionic strength of the solution. In the present thesis an optimal SERS method was
developed for the detection of synthetic cannabinoids. A variety of aggregating agents
and nanoparticles were evaluated using UV/Vis spectrometry, particle sizing and zeta
potential for optimal detection of these compounds. Overall, the best analytical procedure
used 0.0015 MgCl2 to aggregate spherical gold nanoparticles to detect synthetic
cannabinoid parent compounds using a portable Raman spectrometer with a limit of
detection as low as 20 ng/mL in pure samples. Then the optimized SERS method was
tested on two JWH-018 metabolites producing a limit of detection as low as 37 ng/mL.
To determine if the SERS method could be used for practical applications, an
additional study was conducted on spiked urine samples using supported liquid extraction
(SLE) prior to analysis. Since synthetic cannabinoid parent compounds are not commonly
found in urine samples, two JWH-018 metabolites were examined. A few pretreatment
methods prior to extraction were examined to determine the optimal SLE method to
detect synthetic cannabinoid metabolites. However, the SERS spectrum of the JWH-018
metabolites after the extraction did not match that of the pure drug. Therefore, additional
study needs to be conducted to determine other possible extraction methods to detect
JWH-018 metabolites using SERS.
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1. INTRODUCTION
Synthetic cannabinoids are novel psychoactive drugs which were developed to
mimic the effects of marijuana. Control and detection of these drugs is an ongoing
societal problem. Many of these drugs have been adapted, developed and their structures
modified in clandestine labs. These laboratories respond to government controls by
developing new synthetic analogs. As current synthetic cannabinoids become controlled,
newer compounds are being developed, with unknown physiological effects and potency.
Currently utilized detection methods such as immunoassays and targeted HPLC/mass
spectrometry can miss new developed analogs as the chemical structures keep changing.
Therefore, improved methods are needed that can detect these drugs quickly with a
universal detection method. The spectral information obtained via Raman spectroscopy
could be useful in the presumptive identification of unknown compounds, particularly if
combined with a more sensitive detection method such as surface enhanced Raman
spectroscopy. Thus, the goal of my dissertation was to develop a rapid screening
technique for the detection of synthetic cannabinoids at low physiological concentrations
via surface enhanced Raman spectroscopy (SERS).
1.1 Synthetic cannabinoids
1.1.1 Development and structure
Synthetic cannabinoids are a member of the larger and ever-growing category of
designer drugs, also known as novel psychoactive substances (NPS).1 The use and abuse
of synthetic cannabinoids was initially identified in the early 2000s.1 As new synthetic
cannabinoids become scheduled and made illegal by law enforcement, newer
cannabinoids are being synthesized and substituted. Synthetic cannabinoids, known as

1

“K2” or “Spice” were initially sold as smokable compounds that were sprayed or dried on
plant material. 1-3
The first synthetic cannabinoids were developed in the 1960s.1 Over the past 60
years the numbers and types of these compounds has been growing and evolving. The
most common classifications for synthetic cannabinoids are classical, nonclassical,
hybrid, aminoalkylindoles, phenylacetylindoles, tetramethylcyclopropylindoles,
adamantoylindoles, indazole carboxamides, and quinolinyl esters. 1-5 Classical
cannabinoids are those with a similar structure to that of delta-9-THC, such as HU-210.
Nonclassical synthetic cannabinoids are compounds that are derived from
cyclohexylphenol, such as CP 47,497. Hybrid compounds contain structural similarity to
both classical and nonclassical synthetic cannabinoids such as AM-4030.
Adamantoylindoles are commonly split into the four subgroups of naphthoylindoles,
naphthylmethylindoles, naphthoylpyroles, and naphthylmethylindenes.1-5 An example of
a compound from each functional group can be seen in Figure 1.

2

Classical (HU-210)

Nonclassical (CP 47,497)

Hybrid (AM-4030)

Aminoalkylindole (JWH-018)

Phenylacetylindole (JWH-250)

Tetramethylcyclopropylindole (XLR-11)

Adamantoylindole (AKB48)

Indazole carboxamides (AB-PINACA)

Quinolinyl ester (PB-22)

Figure 1: Chemical structures of various synthetic cannabinoids.

3

The initial naming convention of the synthetic cannabinoids was determined by
the location, company, or individuals who initially developed the compounds. The HU
compounds were developed at Hebrew University by Raphael Mechoulam. The CP
compounds were developed by Pfizer. The AM compounds were developed by
Alexandros Makriyannis. The JWH compounds were synthesized by John W. Huffman.3
Naming conventions for newer compounds, however, are determined by the chemical
structure.
1.1.2 Pharmacology and pharmacokinetics
Synthetic cannabinoids were initially developed to identify possible medicinal
uses. John W. Huffman was a part of a National Institute on Drug Abuse (NIDA)
research study that investigated potential therapeutic effects.3 Synthetic cannabinoids
affect the G-protein coupled receptors in the brain, which created an increase in calcium
ions released into neurotransmitter ion channels with a concomitant release of potassium
ions, producing neuronal hyperpolarization.3
Synthetic cannabinoids are CB1 and CB2 receptor agonists. The CB1 receptors are
mainly found in the G protein receptors of the central nervous system. The CB1 receptors
are involved in brain development, memory, pain processing, and movement control. 2,3 In
addition, the CB1 receptors effect glutamate and GABA neurotransmission. A majority of
the CB2 receptors are found in the immune system and mediate immunosuppression.2,3
The metabolites of synthetic cannabinoids have been shown to influence mainly the CB1
receptors. An in vivo and in vitro study by Brents et al. showed that monohydroxylated
metabolites of JWH-018 have a similar affinity to CB1 receptors as that of the parent
compound or delta-9-THC, a main component found in the marijuana plant.6 Synthetic
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cannabinoids have a variety of effects not present after using marijuana, including acute
toxic exposure, including tachycardia, nausea, visual and auditory hallucinations, acute
tubular necrosis and possible seizures or stokes.2 Typical withdrawal effects include
agitation, mood swings, loss of appetite and vomiting. 2 These effects are dependent upon
the absorption and distribution of the synthetic cannabinoids in the body.
Research has been conducted on the effects of absorption and distribution of
synthetic cannabinoids in humans after smoking. In a study by Kacinko et al., one subject
smoked an herbal incense blend containing JWH-018 and JWH-073. Blood samples were
collected 19, 53, 107, and 199 minutes after smoking. The initial concentrations of each
component in blood were 4.8 µg/L (JWH-018) and 4.2 µg/L (JWH-073). After 199
minutes of the concentration of each component dropped down to 0.2 µg/L. Possible
metabolites of JWH-073 were also detected.7 A study by De Jager et al. investigated the
detection of JWH-018 and JWH-073 metabolites in urine from 1.5 to 65 hours after the
individual smoked the blend. The metabolites that they were able to detect in the urine
were JWH-018 N-pentanoic acid, JWH-073 butanoic acid, and JWH-018 N-5hydroxypentyl metabolite.8 A study by Kneisel et al. investigated the detection of
synthetic cannabinoids in oral fluid and serum samples. Eleven different synthetic
cannabinoids were detected in 26 different samples ranging from less than 0.1 to 457
ng/mL in oral fluid and less than 0.1 to 8.3 ng/mL in serum samples.9 Knowing the parent
compounds and metabolites present and amount of samples present in different biological
matrices is important in developing a screening method to detect these and any future
developed compounds.
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Figure 2: Examples of possible metabolic pathways for JWH-073 and PB-22 (PI-COOH
is 1-pentyl-1H-indole-3-carboxylic acid) in urine.1
A variety of metabolic studies have also been conducted on synthetic
cannabinoids. For the naphthoylindole compounds, the phase I metabolites occur via
hydroxylation (on the idole ring or alkyl chain) or oxidative defluorination (on the alkyl
chain). The phase II metabolites occur via carboxylation forming glucuronides. However,
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quinolinyl esters, such as PB-22 have a variety of metabolic pathways to include
hydroxylation, carboxylation, and ester hydrolysis.1 An example of the metabolic
pathways can be seen in Figure 2.
In the detection of synthetic cannabinoids in biological matrices, it is not easy to
pinpoint unique biomarkers for these compounds. Many of these compounds share the
same metabolic pathways. Some synthetic cannabinoids lose a significant part of their
chemical structure undergoing biotransformation.1 To combat these issues, researchers
have suggested either calculating the metabolite ratios of the major metabolites present in
the sample or targeting a specific metabolite that is different between an analogue pair.1,10
1.1.3 Current methods of detection
Many studies have been conducted on the detection of synthetic cannabinoids in
various biological matrices, such as urine, hair, blood, plasma, serum, and oral fluid.
Each matrix presents its own challenges. The use of sample preparation to clean up the
sample matrix prior to instrumental analysis is important because it reduces matrix
interferences when detecting low level compounds. A variety of extraction techniques
have been developed including hydrolysis, liquid-liquid extraction (LLE), solid phase
extraction (SPE), and supported liquid extraction (SLE).
After sample extraction, screening tests are performed to determine the composition
of the sample. Multiple types of tests have been analyzed for this purpose including
immunoassays, gas chromatography-mass spectrometry (GC-MS), and liquid
chromatography-tandem mass spectrometry (LC-MS/MS). The immunoassay is a
measurement that depends on antibody and antigen interactions.11 The types of
immunoassays that have been developed to detect synthetic cannabinoids include
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enzyme-linked immunosorbent assays (ELISA) and homogeneous enzyme
immunoassays (HEIA). With ELISA, the capture antibody binds to the outer walls of the
well plate.12 Then, the sample is added to the plate, where the analyte of interest (the
antigen) binds to the capture antibody. Next, a detection antibody is added, which binds
to the antigen producing a color change. The brightness of the color is proportional to the
amount of the compound present in the sample. 12
Rodrigues et al. determined the LOD and cross-reactivity of nineteen different
synthetic cannabinoids and some of their metabolites using an ELISA immunoassay.13
The immunoassay was developed for the detection of JWH-200. Of the nineteen different
synthetic cannabinoids examined, UR-144 was the only compound that could not be
detected. In addition, 32 oral fluid samples were analyzed and determined to contain
JWH-018, JWH-210, AM-2201, or no controlled substances/metabolites. To confirm the
results of the immunoassay, the oral fluid samples were diluted with a buffer and
analyzed via LC-MS/MS. The results showed that the immunoassay produced false
negative results for samples with a concentration less than 0.36 ng/mL. These samples
were detected via LC-MS/MS.13
A study by Arntson et al. investigated the cross-reactivity of the JWH-018 Direct
ELISA assay and the JWH-250 Direct ELISA assay to detect parent compounds and
metabolites of various synthetic cannabinoids and other controlled substances.14 The
JWH-018 Direct ELISA kit detected a total of 58 different compounds; however, the
JWH-250 Direct ELISA kit detected only 16 of those same compounds. Neither assay kit
detected controlled substances that were not synthetic cannabinoids.14
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Another type of an immunoassay is homogeneous enzyme immunoassay (HEIA).
Compared to ELISA, the HEIA does not require as much sample prep (no washing steps
or long incubation periods), has high throughput, and exhibits low matrix effects.15 The
HEIA immunoassay works similar to an enzyme-multiplied immunoassay technique
(EMIT). In the HEIA immunoassay, the antibody is bound to an enzyme drug conjugate,
6-phosphate dehydrogenase (G6P-DH). The drug used is the compound that you are
trying to detect. An extracted biological sample is added to the assay and competes with
the drug labeled conjugate to bind to the antibody. If the sample displaces the enzyme
drug conjugate, then the released conjugate is free and its attached enzyme converts
nicotinamide adenine dinucleotide (NAD) to NADH, which is measured at 340 nm. The
increased displacement of the enzyme drug conjugate, yields an increase in the amount of
NADH present and permits the quantitative determination of the concentration of the
drug along with structurally similar compounds present in the sample.12,15-17
A study by Kronstrand et al. was conducted involving the analysis of urine samples
via a Spice K2 homogeneous enzyme immunoassay (HEIA) which was capable of
detecting metabolites of JWH-018, JWH-122, MAM-2201, and UR-144.18 The results
showed that the authors were able to detect the various metabolites of each compound
with varying degrees of cross-reactivity. However, the accuracy of the immunoassay was
not acceptable at concentrations below 20 ng/mL and the precision decreased further at
lower concentrations.18 Another study by Barnes et al. used the immunalysis HEIA K2
Spice kit to determine the cross-reactivity of seventy-four different compounds, including
the parent drug and metabolites. Of the seventy-four tested compounds, thirty produced a
low cross-reactivity (between 1-10%) at a concentration of 500 µg/L and twenty-seven
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compounds produced a cross-reactivity less than 1%.15 These results were compared to a
LC-MS/MS capable of detecting all relevant drugs. Prior to analysis samples were
prepared via salting-out liquid-liquid extraction (SALLE). The results of the abovementioned immunoassays demonstrated that while the developed assay kits could detect a
wide range of compounds, the detection of individual compounds was highly dependent
on their structure. Therefore, improved methods need to be developed that can detect a
wider range of presently available compounds as well as any new compounds under
development.
After samples are screened by immunoassay, gas chromatography (GC) or liquid
chromatography (LC) combined with mass spectrometry (MS) are commonly used as a
confirmatory test to identify synthetic cannabinoids in biological samples. Both
instrumental techniques contain two steps. First, the injected sample passes through a
column (the stationary phase) via a gas or liquid (mobile phase) to separate the various
components in the sample. Second, a mass spectrometer detects each separated
component in the sample.19 The amount of time that the sample needs to pass through the
column is determined by the partitioning between the mobile and stationary phase and
depends on the type phase used. After the sample components pass through the column,
they enter the ion source forming ions of various mass to charge ratios. These ions pass
through the mass analyzer and go to the detector. The fragmentation pattern as well as the
abundance of the mass to charge ratio of the fragments obtained for each compound will
vary based upon the ionization source and type of mass analyzer.12 Both single or tandem
mass analyzers have been used.15 Common tandem mass analyzers contain a quadrupole
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as the first mass analyzer, a second quadrupole as a collision cell, and a quadrupole or a
time of flight as a second mass analyzer.12
Many papers have been published on the identification of various synthetic
cannabinoids using these methods. Kavanagh et al. analyzed urine samples of seven
hospital patients thought to be under the influence of drugs. Sixteen urine metabolites of
RCS-4 were identified in the patients via GC-MS. Prior to sample analysis, the urine
samples underwent hydrolysis and derivatization.20 Grigoryev et al. analyzed 20 urine
samples previously determined to contain UR-144 metabolites. Samples were prepared
via LLE and analyzed via LC-MS/MS and GC-MS (which required sample derivatization
prior to use). The authors were able to detect the mono-hydroxylated metabolites of UR144 via LC-MS/MS and GC-MS.21 A study by Heltsley et al. investigated the analysis of
urine samples of US athletes. Samples were prepared via LLE or SPE and analyzed via
LC-MS/MS. Out of the over 5,900 samples, 266 were positive for JW-018 or JWH-073
metabolites. The developed LC-MS/MS method had a n LOD of 1 µg/L.22 Scheidweiler
et al. developed an optimized LC-MS/MS method for the detection of 47 synthetic
cannabinoid metabolites in urine samples. Blank urine samples were spiked with 47
synthetic cannabinoid metabolites, hydrolyzed, and extracted via SLE prior to analysis.
The LOD for the developed method ranged from 0.25 – 20 µg/L.23
While these studies were able to detect a variety of compounds, the methods that
were used have limitations. For example, when using gas chromatography, the
compounds of interest need to be volatile. If a compound is not volatile, then a
derivatizing agent needs to be added to the sample prior to injection.21 In addition, GCMS and LC-MS/MS have a long analysis time. Immunoassays are a quick and easy

11

presumptive test; however, current immunoassays might not be able to detect newer
synthesized compounds as the chemical structures for these compounds are always
changing. Furthermore, variations in cross reactivity can limit detection and reduce
sensitivity. Therefore, additional work is needed to develop instrumental techniques
capable of detecting the currently available cannabinoids as well as those that will be
developed in the future. A screening method needs to have good sensitivity and high
selectivity. One current instrumental technique that can has this capability is surface
enhanced Raman spectroscopy.
1.2 Raman Spectroscopy
Raman spectroscopy is a vibrational spectroscopic technique. A monochromatic
laser beam irradiates the sample producing scattered light that is sent to the detector,
where the signal is converted to a visible spectrum. The lasers commonly used in Raman
spectroscopy produce an intense beam within the visible/near IR spectrum with typical
wavelengths from 500 - 1000 nm. The most common detectors used are multichannel
charge-coupled devices (CCD), single element low band gap semiconductors, or electron
multiplication CCD detectors, which help convert the data received into an electrical
signal. The Raman spectra produced are measured in the infrared region of the
electromagnetic spectrum (commonly 400 - 4000 cm-1).24,25 The Raman spectrum
produces an individualized “chemical fingerprint” for the sample depending on the
vibrational frequency of each chemical component produced via Raman scattering.

12

Lowest
excited
electronic
state

V=3

Rayleigh
Scattering
ES = EL

Anti-stokes
Scattering
ES = EL+ hωv

Stokes
Scattering
ES = EL- hωv

V=2
V=1
V=0

Virtual
state

hωv

V=3
V=2
Ground
electronic V=1
state
V=0

ΔE

Stokes

Figure 3: A simplified Jablonski diagram showing Rayleigh, anti-Stokes, and Stokes
scattering, where ELis the incident photon energy from the laser, Es is the scattered
energy produced and hωv is the energy of the vibration (above). An example Raman
spectrum showing the difference in signal intensity between Stokes and anti-Stokes
scattering (below).24,25
The scattered light produced, via the laser irradiating the sample, is elastic,
(Rayleigh scattering) and inelastic (Raman scattering). In Rayleigh scattering, the
molecule is excited to a virtual state and produces an emission that ends back at the
original ground electronic state (Figure 3).24,25 Rayleigh scattering cannot be
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distinguished from the frequency of the incident beam, and therefore cannot be used for
the structural interpretation of any compounds. With Raman scattering, the absorbed
photon is reemitted at a different intensity that is 1/100000 of the intensity of the incident
beam, which results in a spectrum which is characteristic of the molecular absorbance of
the molecule.24,25
The difference in the vibrational frequencies produced via Raman scattered light
is measured as a series of negative (Stokes) or positive (anti-Stokes) shifts from the
incident beam frequency. In Stokes scattering, the molecule is excited at the lowest
energy state to a ‘virtual state,’ then it produces an emission that ends at the energy state
higher than originally started. In anti-stokes scattering, the molecule is excited at the
lowest energy state, to a similar ‘virtual state,’ then produces an emission that ends at the
energy state lower than originally started (Figure 3).24,25 Since more molecules are
originally located in the lower energy states, stokes scattering will produce higher
intensity spectra than anti-stokes (Maxwell-Boltzmann distribution law). Therefore, the
stokes side of the spectrum is typically used for analysis.24,25
The detection of a target compound via Raman spectroscopy requires a change in
the polarizability of various bonds (vibrational modes) forming the compound. As the
laser hits the compound, producing Raman scattering, the electrons around the various
bonds in the compound are momentarily distorted, which creates a molecule that is
temporarily polarized, resulting in an induced dipole. The variation in the polarizability
of various vibrational modes in the compound creates results in the creation of the peaks
present in the Raman spectrum. The Raman signal intensities of these peaks are directly
proportional to the concentration of the molecule.25,26 The Raman spectrum produced is
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recorded in wavenumbers (cm-1) versus signal intensity. Further detail on the spectral
interpretation of the various synthetic cannabinoids examined in this study will be
discussed in chapter 6.
The weakness of the conventional Raman technique is that the compound must be
present at a sufficient concentration to produce a detectable Raman signal. In research
conducted by Weyermann et al., samples of cocaine, heroin, and amphetamine could only
be detected at concentrations as low as 1 mg/mL in diluted deionized water and drug
mixtures were hard to discriminate.27 As a result, conventional Raman cannot analyze
samples at physiological concentrations.
1.3 Surface Enhanced Raman Spectroscopy
In 1974, surface enhanced Raman spectroscopy (SERS) was developed by
Fleischmann et al. which enabled the analysis of samples at physiological concentrations.
In their research, an enhancement of the Raman spectrum from pyridine adsorbed on a
roughened silver electrode was observed.28 Their discovery led to acceleration in the
research involving Raman spectroscopy. Surface enhanced Raman spectroscopy uses a
metal substrate to produce a signal enhancement that is several orders of magnitude
greater than the signal produced from conventional Raman spectroscopy. The substrate
may be a roughened metal surface or an aggregation of nanoparticles. There is an
advantage to using nanoparticle solutions, as they provide a fresh surface with each use
and signals ca be further enhanced through the use of aggregating agents.
1.3.1 Nanoparticle formation
Nanoparticles are formed through the coalescence and nucleation of reduced
metallic salts. There are a few theories on nanoparticle nucleation and growth. The most
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common theory is the La Mer mechanism, which describes the nucleation and growth as
a three-step process.29 Initially, there is a rapid formation of monomers, the free metal
ion, in solution. Then, the metal ion undergoes “burst nucleation.” Once an abundance of
the free metal ion is formed, the metal ions close together to form nanoparticles. At the
time when no additional nucleation occurs, then the existing monomers bind to the
current nuclei forming larger particles. Finally, the metal ions disperse throughout the
solution creating nanoparticles of various sizes (Figure 4).29 The concentration of the
monomer affects the time needed for phase II to be completed. An increase in the
concentration of the monomers leads to additional time needed to complete nucleation.

Figure 4: A simplified diagram of the La Mer mechanism showing nanoparticle
nucleation and growth of gold nanoparticles in solution using trisodium citrate as the
reducing agent.29
The formation of nanoparticle sizes in solution have been explained via Ostwald,
as digestive, or intraparticle ripening. In Ostwald ripening, the smaller formed
nanoparticles break apart in solution and bind to the bigger nanoparticles to form large
nanoparticles. The above is caused by the surface energy and high solubility of the
smaller nanoparticles.29 In digestive ripening, the formed nanoparticle, because of surface
energy of that particle, breaks apart to form smaller nanoparticles. 29 In intraparticle
ripening, there is a separation of the metal ions on the outer formation of the nanoparticle,
which changes the shape of the nanoparticle. The above happened because of the surface

16

energy of the different monomers of the nanoparticle. 29 Another mechanism to describe
nanoparticle nucleation and growth is the Finke-Watzky two step mechanism. In the twostep mechanism, two events are happening simultaneously: the slow nucleation of the
metal and the growth of the nanoparticle via a catalyst. 29 The Finke-Watzky two step
mechanism process of the nucleation and growth of gold nanoparticles cannot be
conducted without the use of a reducing agent. A common reducing agent in spherical
gold nanoparticle synthesis is trisodium citrate.
A study by Chow et al. showed that the concentration of the trisodium citrate
added to the heated tetrachloroauric acid solution can affect the pH of the solution and
cause two different reaction pathways for gold nanoparticle nucleation.30 By keeping the
pH between 3.7 – 6.5, the tetrachloroauric acid forms a [AuCl3(OH)]- intermediate that
undergoes a LaMer bust nucleation for less than 10 seconds, then a fast random
attachment, and finishes with intraparticle ripening. If the pH is between 6.5-7.7, there is
a reduction of the tetrachloroauric acid forming [AuCl3(OH)]2- and [AuCl3(OH)]3intermediates which undergo a long nucleation (around 60 seconds) followed by slow
growth.30
Upon the completion of the nucleation and growth of the gold nanoparticles in
solution, the stern (outer) layer contains the citrate trianions. Park et al. studied how the
citrate anion bonds with the nanoparticles to produce an electrostatically stable
nanoparticle solution using a variety of instrumental techniques.31 They concluded that a
citrate layer forms from dihydrogen citrate anions adsorbing onto the gold nanoparticle
surface, which hydrogen bond with other dihydrogen citrate anions already adsorbed in
the gold nanoparticle surface and hydrogen bond with other citrate anions creating citrate
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chains. These formed citrate chains interact with each other via Van der Waals
interactions.31 With each nanoparticle having a negatively charged stern layer, there is a
steric repulsion between each nanoparticle allowing the nanoparticle solution to be
electrostatically stabilized.31 To detect compounds of interest in solution, an aggregating
agent is added to destabilize the nanoparticles in solution in order to produce the SERS
enhancement through the development of enhanced local fields at points of interaction
between the particles.
1.3.2 Mechanism of SERS
For the SERS effect to take place, the compound of interest must be adsorbed or
within about 10 nm of the metallic surface to produce an electromagnetic interaction.25,32
There are two main theories on the mechanism for enhancement that occurs in SERS,
which involve chemical and electromagnetic effects respectively. 25,32 In both theories, the
Raman signal is the result of an interaction between the induced dipole moment (P), the
electric field (E), and the polarizability (α) of the molecule. As the molecule interacts
with the metal substrate, localized variations in the electric field alter the polarization of
the molecule and its dipole moment resulting in an enhancement of the Raman signal.
However, the process of enhancement can vary depending on the molecular structure and
surface. The two theoretical descriptions attempt to explain these factors through
electromagnetic and chemical effects.
In the electromagnetic theory, the electric field of the molecule is enhanced by the
electromagnetic effect produced by the metal surface that results from the collective
excitation of the electron cloud near the surface (surface plasmons). Regardless of the
exact mechanism of enhancement, the excitation of the surface plasmon greatly increases
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the local field experienced by a molecule adsorbed on the surface of the metal. In the
same way, the metal also enhances the Raman scattered field.25,32
First, one must understand why metals are used for detection of low
concentrations of various compounds. The electrical and optical properties of a metal can
be characterized by its dielectric function ϵ(ω), where ω is the frequency of light. The
frequency of light can be calculated using the equation ω = 2πϲ /λ, where ϲ is the speed of
light and λ is the wavelength.32 Therefore, the dielectric function can be related to ω or λ.
The dielectric function of a metal with respect to a specific wavelength ϵ(λ), at a given
wavelength, is characterized by real and imaginary parts. 32
Within the visible range of the electromagnetic spectrum, the real part of the
dielectric function is large and negative. At long wavelengths, the real part of the
dielectric function can be determined by the lossless Drude model:
𝜔2

𝜆2

∈=∈∞ (1 − 𝜔𝑝2 ) =∈∞ (1 − 𝜆𝑝2 )

(1)

where ωp, the plasma frequency, and is equivalent to 2πϲ/λp. However, metals are not
lossless, having no dissipation of electromagnetic energy. Therefore, there is an
imaginary portion of the dielectric function that is important.32 The imaginary portion is
related to the absorption of the metal. The dielectric function in relation to wavelength for
gold metal contains additional contributions from free electrons, which give it a higher
absorption when compared to other metals, such as silver.32 Upon understanding the
dielectric function of a metal, one can understand the electromagnetic properties of the
metal, such as reflectance.
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Upon an incident electromagnetic wave hitting a metal surface at a specific wave
vector, reflected and transmitted waves at a specific wavevector result. The amplitude of
the transmitted waves is the result of the index of refraction of the metal, which is related
to the dielectric function, 𝑛 (𝜔) = √𝜖(𝜔). The intensity of the reflected light is
determined by the Local Field Intensity Enhancement Factor (LFIEF). 25,32 The LFIEF is
the normalized value of the square of the electric field amplitude at a specific point
divided by the normalized intensity of the incoming field at
𝐿𝐹𝐼𝐸𝐹 (𝑟) = |𝐸(𝑟)|2 /|𝐸0 (𝑟)|2

(2)

that specific point. The LFIEF is dependent upon the frequency and wavelength at the
specific point and therefore the LFIEF can be rewritten as:
𝐿𝐹𝐼𝐸𝐹 (𝑟, 𝜔) = |𝐸(𝑟, 𝜔)|2 /|𝐸0 (𝑟, 𝜔)|2

(3)

The LFIEF could be greater than or less than 1, depending upon if the local field is
enhanced or quenched.25,32
In a traditional sense, the LFIEF on a flat surface for a normal incidence
excitation of a bulk metal, such as gold, from air would be quenched. However, if the
gold was a lossless metal, an electromagnetic field would be created on the surface of the
metal. If the metal is lossless, then there is no dissipation of electromagnetic energy.
When the incident wave from the laser hits the electromagnetic field of the metal, it sends
the incident electromagnetic wave in the opposite direction.25,32 However, at high
reflectivity, a low LFIEF can be achieved on the surface of the metal. Other LFIEFs can
be achieved at different angles, which are dependent upon the incident angle of
polarization.25,32 In addition, the type of metal used, and its shape can have an effect on
the local electric field.
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In my study, spherical gold nanoparticles were used to produce the SERS
enhancement. To gain an understanding of what happens to the electromagnetic field
around the gold nanoparticle, Maxwell’s equations can be used with set boundary
conditions.25,32 To simplify the mathematical solutions, electrostatic approximation can
be used to explain the effects of an electromagnetic field on a metal. In electrostatic
approximation, the applied electric field of the metal has a uniform field that oscillates at
a specific frequency, but not in a direction of a specific vector or wavelength. The
electrostatic approximation is valid for nanoparticles less than 10 nm; however, it can be
applied for larger objects.25,32 The electrostatic problem of a sphere can be solved
understanding that the sphere has an induced dipole at a specific origin 𝜌 and surrounding
the nanoparticle is an applied external field. The magnitude of the induced dipole can be
calculated as follows:
𝜖(𝜆)−𝜖

𝜌 ∝ (𝜖(𝜆)+2𝜖𝑀 )
𝑀

(4)

The dielectric function ϵ(λ) is a complex number having a real, Re[ϵ(λ)], and imaginary,
Im[ϵ(λ)], portion. While the real portion of the dielectric function can achieve Re[ϵ(λ)] =
-2ϵM (implying that 𝜌 → ∞), this cannot be achieved by the imaginary portion of the
dielectric function. Therefore, the magnitude of Im[ϵ(λ)], however small, is the
magnitude of 𝜌 at a specific wavelength and called the localized surface plasmon
resonance of the sphere.25,32
The part of the spherical nanoparticle that has the largest local field enhancement
are the two points, in the direction of the external electric field, that go through the center
of the sphere. The LFIEF at a specific area of a spherical nanoparticle can be calculated
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and will occur over a specific wavelength range, where Re[ϵ(λ)] = -2ϵM is satisfied, based
upon the metal used.25,32 For example, the LFIEF’s can be estimated at a specific point on
gold and silver spherical nanoparticles. While the LFIEF has a higher signal intensity for
silver over gold nanoparticles, gold has a broader wavelength range where Re[ϵ(λ)] = 2ϵM can be achieved. The intensity of excitation over this broad wavelength range for
gold spherical nanoparticles is smaller due to the larger Im[ϵ(λ)] at the corresponding
resonance frequency.25,32
Another factor to consider is the size of the nanoparticle. The electrostatic
approximation works for nanoparticles less than 10 nm. Nanoparticles ranging from 30 to
100 nm can have size effects. First, the LSP resonance varies depending upon the size of
the nanoparticle. As the nanoparticle size increases, the LSP resonance shifts to a higher
wavelength (red shift). Second, the LFIEF decreases as the nanoparticle size increases,
broadening the resonance. Third, the nanoparticles ranging from 30 to 100 nm produce
multipolar resonances that do not effectively couple with incident radiation to produce a
strong LFIEF.25,32

Induced dipole

E

‘hot spot’

Induced dipole

Figure 5: The interaction between two gold nanoparticles producing ‘hot spots’ after an
external applied electric field (E).
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In addition to the effect of a single particle with plasmon resonance, the
interaction between two or more close particles (coupled plasmon resonance) can affect
SERS enhancement. The interaction between the two particles is caused by the induced
dipoles of the two or more particles. These interactions create electromagnetic ‘hot spots’
(Figure 5). The closer the particles are to each other, an increase in the intensity of the
local field intensity enhancement occurs, creating a stronger Raman signal intensity that
produces a red shift of the Raman spectrum.25,32 The highest signal intensity is located at
the area of closest contact between the two particles. A variety of metallic substrates in
various forms have been tested in surface enhance Raman spectroscopy, which includes
gold, copper, silver, and alkali metals. Of those metals, the most prominently used metals
have been gold and silver because of their strong plasmon resonance.25
In addition to the electromagnetic theory, there are other factors, such as chemical
enhancement, that affects SERS enhancement. Chemical enhancement is the change in
the polarizability of the metal nanoparticle following adsorption of the compound of
interest onto the metal nanoparticle surface. Chemical enhancement can result in the
quenching (not being able to see the compound of interest) or enhancement (via a chargetransfer mechanism) of the SERS signal.25 There are three different ways at which
charge-transfer mechanism can be explained. First, the metal nanoparticle does not bind
covalently to the analyte of interest, but causes a change in the electronic distribution of
the analyte, which changes the Raman polarizability.25 Second, the addition of a surface
complex could covalently bind to the metal or indirectly binds to the metal via an
electrolyte ion and change the polarizability. Chloride is an example of an electrolyte ion.
Third, is a photon-driven charge transfer between the metal and the analyte of interest.25
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1.3.3 Improvement of enhancement through aggregation
As stated previously, spherical gold nanoparticles can be formed using sodium
citrate as the reducing agent, which creates stabilized negatively charged nanoparticles.
In order to detect the compound of interest via SERS enhancement, the nanoparticles
need to become destabilized to create electromagnetic ‘hot spots.’ One way to destabilize
the nanoparticles is the use of an aggregating agent.
Despite having some understanding about aggregation, the exact mechanism for
which destabilization is still unknown. One theory is that the anion of the aggregating
agent displaces the citrate surrounding the nanoparticle, reducing the repulsion between
particles. The above theory is thought occur specifically with chloride and other salts
(Figure 6).25 However, as important as the anion is to nanoparticle destabilization, the
cation could also have an effect.

Figure 6: A basic diagram of one possible mechanism of nanoparticle destabilization via
chloride ion deplacement.25
A variety of studies have been published on the destabilization of gold
nanoparticles using various salts. A study by Kim et al. looked at the change in
absorbance, nanoparticle size, and zeta potential with the use of benzyl mercaptan as the
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aggregating agent. The peak of the surface plasmon band of gold nanoparticles via
sodium citrate reduction is typically around 520 nm. After the addition of the aggregating
agent, there was a red shift in the UV-vis spectrum, shifting the surface plasmon band to
720 nm, and continuing to shift to higher wavelengths as the concentration of the benzyl
mercaptan increased.33 As the concentration of the benzyl mercaptan increased, the
average nanoparticle size increased and the zeta potential decreased. In addition, there
was a color change from red to blue after the addition of the aggregating agent. The
authors believed that the addition of the benzyl mercaptan to the nanoparticle solution
caused the benzyl mercaptan to displace the citrate ions surrounding the nanoparticles
causing a change in the stability ratio and bringing the nanoparticle closer together for
SERS enhancement.33
Another factor involves the effect of an aggregating agent’s ionic strength on the
color change that occurs during nanoparticle destabilization. Burns et al. titrated various
monovalent, divalent, and trivalent sulfate, nitrate, phosphate, and chloride salts into a
gold nanoparticle solution until a color change occurred. Prior to and at the titration end
point, the UV-vis absorbance, nanoparticle size, and zeta potential were recorded.34 The
concentration of the aggregating agent at the titration end point was determined. From the
above information, the ionic strength, activity coefficient, and Debye length (nm) were
calculated. The Debye length is the calculated particle-to-particle mean distance between
nanoparticles in solution.34
The results showed that the multivalent salts reached the titration endpoint at a
lower concentration than monovalent salts. The same trend was seen with ionic strength.
However, there was no correlation to Debye length. The particle-to-particle mean
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distance varied between monovalent, divalent, and trivalent salts and was not related to
the color change of the nanoparticle solution.34
Similar to Kim et al., there was a red to blue color change of the nanoparticle
solution as a result of a red shift in the UV-vis spectrum, and a decrease in the zeta
potential. However, the zeta potential changed from a negative to a positive number at the
titration endpoint. The charge of the zeta potential of a nanoparticle solution is related to
the charge of the reducing agent.34 If gold nanoparticles were formed via a sodium citrate
reduction, then the zeta potential would be is negative. The change from negative to
positive means that the stern layer of the nanoparticle has become positively charged
after the addition of the aggregating agent. Therefore, the authors believed that the cation
of the aggregating agent influences nanoparticle aggregation and the color change was
the result of the cation surface absorption.34 The results of these two studies, show that
aggregation of the nanoparticles could be caused by both the cation and the anion of the
aggregating agent.
Another way to examine the effect of monovalent cations and various anions of
aggregating agents is to utilize the Hofmeister series as a driver for critical coagulation
concentration (CCC). The Hofmeister series is a list of specific cations and anions with
respect to their capability to salt-out or salt-in proteins. The CCC is the demarcation
between fast and slow nanoparticle aggregation. A study by Oncsik et al. determined the
CCC for monovalent salts when mixed with positively and negatively charged latex
nanoparticles. The more hydrated cations and anions reached the CCC at a higher
concentration than the least hydrated cations and anions.35 Additional work by Pavlovic
et al. studied the CCC for multivalent anions. For PO43-, Fe(CN)63-, and Fe(CN)64-, more
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than one CCC was discovered as the concentration of salts with those anions increased
when added to MgAl–NO3–LDH particles. The authors believed that it could have been a
consequence of hydrogen bonding, hydrophobic interactions, or electrostatic
interactions.36 Prior to my research, no research had been conducted to determine the
CCC of salt with multivalent cations (see Chapter 4).
1.4 SERS for Drug Detection
In recent years, there has been a significant increase in analytical and forensic
applications of Raman spectroscopy. The development of portable Raman spectrometers
that are light, easy to carry, and produce fast results has accelerated the trend. The various
forensic applications include questioned document examination, explosives/gunshot
residue, trace evidence, DNA, and drug analysis. Within questioned documents, SERS
analysis has been conducted on pen inks, printer inks and toners.37,38 Silver colloids have
been used to differentiate between various black and blue gel and liquid pens37 and to
differentiate between four different jet ink dyes printed on five different types of paper.38
In regard to trace analysis, studies were conducted on fibers and paints to detect
various pigments on dyes within the various forms of art. As a consequence of
background interferences, silver colloids could not be used to detect pigments and dyes
on fibers. Instead, a silver paste was developed to detect various pigments and dyes on an
art piece by Mariano Fortuny.39 Gold nanoparticles on silicon or carbon coated surfaces,
which formed monolayers of linear arrays, were able to detect RDX and ammonium
nitrate.40 In addition, research has been conducted combining Polymerase Chain Reaction
(PCR) with SERS to detect specific DNA and RNA sequences using silver colloids
printed on filter paper and applied to a region on a dipstick. 41
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Multiple articles have been produced showing the ability to detect various drugs via
SERS. Silver nanoparticles have been used to detect morphine, codeine and hydrocodone
in trace quantities with NaCl as an aggregating agent. 42 The spectra produced provided
enough spectral information to differentiate these three structurally similar molecules as
well as providing assignment to how the molecules interact with the nanoparticles. Yet,
the detection limits were not determined, and spectra were produced with the addition of
one microgram of the drug of interest.42
Surface enhanced Raman spectroscopy has also been applied to drugs commonly
found in drug facilitated sexual assaults (DFSA). In previous work by Cîntã et al., the
analysis of diazepam and nitrazepam was performed on silver colloid surfaces in aqueous
solution.43 The nanoparticles were synthesized using borohydride reduction. The drugs
were detected and identified at a concentration of approximately 30 ng/mL with
excitation wavelength of 488 nm. Though the structures are very similar of these two
compounds, they could easily be distinguished based on differences in Raman vibrational
frequencies.43
In a recent study, 11 different benzodiazepines were studied using gold nanoparticles
and four different aggregating agents (MgCl2, CaCl2, KCl, and NaCl).46 The gold
nanoparticles were prepared using the reduction of hydrogen tetrachloroaurate with a 1%
sodium citrate solution. The limits of the detection of the various benzodiazepines were
determined to be 50 ng/ml or lower with an excitation wavelength of 785 nm. On the
basis of the results, the best aggregating agent to use was (1.67M) MgCl 2. All
benzodiazepines could be easily distinguished using differences in Raman vibrational
frequencies at a concentration of 250 ng/mL.44 Spiked urine samples containing
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benzodiazepines were detected at concentrations as low as 0.5 ng/mL. Prior to SERS
analysis, the benzodiazepines had to be extracted from the urine using supported liquid
extraction (SLE).45
Only a few articles have been published on the use of SERS to detect various designer
drugs.46-48 Mephedrone using SERS and a portable Raman spectrometer using gold and
silver nanoparticles. However, the limit of detection for the optimal method was not
determined.47 Farquharson et al. analyzed a variety of drugs in saliva, including MDMA,
using SERS via a portable Raman spectrometer. On the basis of their analysis, all 14
drugs could be discriminated from each other via their Raman shift.48 Alphapyrrolidinopentiophenone (α-PVP) could be detected at concentrations as low as 0.01mM
using silver nanoparticles.49 Stewart et al. looked at a variety of cathinones of which
could be easily distinguished from one another.46
Prior to starting this research study, no research had been published on SERS
detection of synthetic cannabinoids. Since our first publication, additional work on
synthetic cannabinoids has been conducted, see Chapter 3. Silver nanoparticles have been
used detect AMB-FUBINACA at concentrations as low as 0.01mM.49 In addition, using a
hydroxylamine phosphate silver (HPAg) colloid and NaCl as the aggregating agent, 5FPB-22 could be detected at concentrations as low as 2.12 × 10-8 M.50
2. GOALS AND OBJECTIVES
The goal of my thesis was to produce a surface enhanced Raman spectroscopy
(SERS) technique that would be able to detect synthetic cannabinoids from biological
samples at low physiological concentrations. The technique needed to use a rapid
extraction method that, paired with SERS, could be used as an alternative to the
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traditional immunoassays. The SERS procedure would be able to detect the current
synthetic cannabinoids as well as the future development of other synthetic cannabinoids
and other designer drugs due to the unique Raman spectrum of each compound.
Therefore, SERS could be useful in a clinical setting to assess drug overdose as well as
forensic toxicological analysis.
The study includes three main objectives. The first objective was to assess the use
of SERS as a method for the screening of synthetic cannabinoids using previously tested
methods. The second part of the study was to further investigate SERS enhancement in
order to develop an optimal SERS method for the detection of synthetic cannabinoids.
Gaining a better understanding of the nanoparticle and aggregating agent interaction
would help determine the optimal aggregating agent and aggregating agent concentration
needed for SERS analysis of synthetic cannabinoids. The final part of the study was to
assess the use of supported liquid extraction as a technique to detect synthetic
cannabinoids in simulated urine samples. Data collection and analysis involved
observation of the Raman spectral analysis of each synthetic cannabinoid, calculation of
analytical figures of merit, and analysis of simulated/spiked urine samples.
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3. INITIAL ASSESSMENT OF A SERS METHOD FOR THE DETECTION OF
SYNTHETIC CANNABINOINDS
This article was published in Talanta, 164, Mostowtt T, McCord B., Surface enhanced
Raman spectroscopy (SERS) as a method for the toxicological analysis of synthetic
cannabinoids, 396-402, Copyright Elsevier (2017).
3.1 Abstract
Synthetic cannabinoids (K2, spice) present problems in forensic investigations
because standard presumptive methods, such as immunoassays, are insufficiently specific
for the wide range of potential target compounds. This issue can lead to problems with
low sensitivity and yield false negative results. A potential solution to this problem is
surface enhanced Raman spectroscopy (SERS). In this study we demonstrate the analysis
of a set of structurally similar synthetic cannabinoids using SERS.
The procedure involves mixing the analyte with gold nanoparticles prepared in a
solution containing alkali or alkaline earth salt solutions. The salts produce aggregation
of the nanoparticles with a resultant spectral enhancement due to the formation of
spectral hotspots with enhanced field effects within the aggregate. Among the salts tested,
0.0167 M MgCl2 produced the lowest limit of detection and best overall sensitivity. The
method produces clearly distinguishable spectra for each synthetic cannabinoid with
detection limits as low as 18 ng/mL. Spiked urine samples were also analyzed following
a cleanup procedure involving support liquid extraction. When using a portable Raman
system, a higher concentration of MgCl2 was needed to produce similar a LOD. The
results demonstrate that this procedure has great potential as a method for presumptive
screening of synthetic cannabinoids.
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3.2 Introduction
The use and abuse of synthetic cannabinoids has increased significantly in recent
years. Originally, these drugs were sold in retail outlets or via the internet and labeled as
“not for human consumption” to avoid any possible regulation of the products by the
Food and Drug Administration (FDA). In these internet or retail outlets, synthetic
cannabinoids are sold as “K2” or “spice”.51 With easy access, any individual of any age
could purchase the drug giving easy access making them very popular.
This upsurge in popularity has led to a concomitant increase in drug seizures and
emergency room visits around the world. The number of emergency room visits in the
United States involving the use of synthetic cannabinoids increased from over 11,000 in
2010 to over 28,000 in 2011.52 Over 75% of those visits involved people from the age of
12–29.52 In Europe, 36 people were hospitalized, following the abuse of MDMBCHMICA in one month of 2016.53 There have also been incidents in South Korea and
other parts of the world.54
Many of these drugs are made in small, unregulated laboratories and easily
shipped around the world using standard carriers.55 The response of public officials to
this issue has been to make these problematic drugs illegal. Unfortunately, once a
compound is listed and becomes illegal to possess, new synthetic analogs are quickly
developed and distributed. The resultant plethora of new and dangerous compounds
presents a continuing problem in forensic investigation and laboratory work as standard
methods may not detect the new drug targets.
Although confirmatory testing of many drugs of abuse can be performed using
advanced methods such as GC-MS and LC-MS,56,57 it is important to have a robust and
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reliable screening method. For toxicological investigations, the most commonly used
technique is the immunoassay.14,58 As an example, Spinelli et al. performed a validation
study on a commercial immunoassay system developed to target the JWH-018 Npentanoic acid metabolite. To assess the immunoassay's cross-reactivity, 73 synthetic
cannabinoids (500 μg/L concentration) were examined. Of these 73 compounds, 19
synthetic cannabinoids produced none or less than 1.2% cross-reactivity.59 Similarly,
Barnes et al. looked at the cross-reactivity of a different commercial immunoassay. Their
study of 73 cannabinoids examined at a concentration of 10 μg/L found that only 17 of
the compounds produced a cross-reactivity of 10% or higher, clearly indicating potential
problems with false negatives.15 Although some immunoassays are highly sensitive for
their targets and can be rapidly performed,14 current immunoassay testing of
cannabinoids is very limited and the tests respond poorly (low cross reactivity) when
confronted with the wide range of differing designer drug structures.
Because of these problems, new procedures involving GC-MS and LC-MS, have
been developed for screening synthetic cannabinoids and other designer drugs. 18,57,60,61
For GC-MS, sample preparation for this method involves an extraction of the drugs from
the biological matrix and derivatization, which is necessary in order to produce volatile
compounds.56,57 Both of these methods have limits of detection as low as 0.1 ng/mL and
there is a wide range of samples that can be detected.18,57,60,61 Unfortunately, many
hospital laboratories lack the expertise to perform this kind of complex analysis in a
timely fashion, and the instrumentation is costly to run and maintain. A general
immunoassay for dangerous drugs may be the only available test, resulting in false
negatives when synthetic drug analogs are tested.
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Many samples left undetected by immunoassay may never be investigated further.
In the study performed by Spinelli et al., over 2400 previously tested authentic case urine
samples were examined. Upon analysis, 57 false negatives were produced at a cut-off of
5 μg/L and 87 false negatives were produced at a cut-off of 10 μg/L.59 The above issue
with false negatives and lack of cross-reactivity is a likely result of poor cross-reactivity
between designer drug structures.
The inevitable problem with immunoassays is that the procedures targets one
particular compound or structural type. The wide range of synthetic cannabinoids
available virtually guarantees that screening via immunoassay will cause false negatives.
An alternative procedure is needed that is flexible, specific and sensitive. For this reason,
we have been investigating surface enhanced Raman spectroscopy for use in screening
synthetic cannabinoids. Because immunoassay tests are class and not compound specific,
even a positive result cannot provide much guidance for subsequent confirmation by GCMS or LC-MS. Instead, itis an orthogonal method that produces unique spectra for each
compound. This however is not the case for Raman spectroscopy.
Unlike conventional Raman techniques, surface enhanced Raman Spectroscopy
(SERS) has sufficient sensitivity to detect these drugs at low physiological conditions.
The initial SERS procedure was developed by Fleischmann et al. in 1974.28 In these early
experiments, it was discovered that the Raman signal was greatly enhanced when the
sample was deposited on roughened metal surfaces. The effect was believed to result
from the result of electric field enhancements on the metal surfaces that accentuated
interactions between adsorbed compounds and surface plasmons. Later work by Lee and
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Miesel demonstrated that similar enhancements could be created in a solution containing
metallic nanoparticles.62
Recently, there has been a renewed interest in SERS as a screening tool for trace
analysis.63,64 SERS has been employed for the identification of trace identification of
certain controlled substances. The drugs previously examined have included
amphetamines,27,64-68 opiates,27,65,69,70 benzodiazepines,43-45 and designer drugs.49,50
In previous work in this laboratory we have demonstrated the application of SERS
for the detection of benzodiazepines in aqueous and toxicological samples at
concentrations as low as 0.5 ng/mL.44,45 During a study of potential interferences with
this technique, we were able to determine that THC could be detected at concentrations
as low as 5 ng/mL. For this reason, we began to examine the SERS spectra of natural and
synthetic cannabinoids. In this study, four synthetic cannabinoids were examined, JWH073, JWH-018, JWH-081, and JWH-122. The structures of these compounds are
relatively similar and are shown in Figure 7. The overall goal of the project was to
determine if SERS could differentiate and detect synthetic cannabinoids of a closely
similar chemical structure at low ng/mL concentrations. To our knowledge this is the first
description of the application of SERS for synthetic cannabinoids.

JWH-081

JWH-122

Figure 7: The chemical structure of the 4 different synthetic cannabinoids examined in
this study.
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3.3 Materials and Methods
3.3.1. Drugs examined
All DEA scheduled drugs JWH-018 (LOT# 1294.1B3.2), JWH-073 (LOT#
1293.1B1.2), JWH-081 (LOT# 1505.1B1.1), and JWH-122 (LOT# 1491.1B1.1) were
obtained from Lipomed AG. All of the DEA scheduled drugs were obtained in powder
form and diluted to 0.2 mg/ mL in methanol. The above solution was then used to create
stock standard solutions ranging from 25 to 20,000 ng/mL in 10% methanol.
3.3.2. Aggregating agent optimization
The following procedures used for SERS development and analysis were similar
to those followed by Doctor et al.44 100 mL gold nanoparticle solutions were prepared
reducing tetrachloroauric (III) acid trihydrate (Acros Organics, LOT#A0354619) with 4
mL of a 1% by weight solution of trisodium citrate dihydrate (Fisher Scientiﬁc, LOT#
091236). Chlorates, nitrates, and sulfates were used as aggregating agents to help
determine the optimal aggregating agent and concentration used for SERS analysis. The
previous study by Doctor et al. only looked at chloride salts as aggregating agents.
Initially, 1.67 M stock solutions of MgCl2, (Fisher Scientiﬁc), CaCl2 (Fisher Scientiﬁc),
KCl (Spectrum), NaCl (Sigma-Aldrich), MgSO4 (Fisher Scientiﬁc), Na2SO4 (Spectrum),
and KNO3 (Sigma-Aldrich) were examined in SERS analysis. Based upon initial results,
further analysis was examined using stock concentrations of 0.835 M, 1.25 M, 2.5 M and
3.34 M of MgCl2. After the preparation of the above solutions, the SERS samples for
analysis were prepared as follows. First, 980 µL of the gold nanoparticle solution was
placed in a clear 2 mL sample vial (Fisher Scientiﬁc) followed by 10 µL of a select
aggregating agent solution and vortexed for 30 s. Then, 10 µL of the drug stock standard
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solution was added to the 2 mL sample vial and vortexed for 30 s. The ﬁnal concentration
of each solution, in the gold nanoparticle solution was as follows: 0.05 mM HAuCl 4,
0.0835–0.334 M of aggregating agent, and between 2.5–2000 ng/mL of a synthetic
cannabinoid.
3.3.3 Simulated urine samples
Upon the optimization of the above method, spiked urine samples of JWH-018,
JWH-073, JWH-081, and JWH-122 in pure methanol were analyzed using supported
liquid extraction (SLE). For sample pretreatment, a 1:1 solution of spiked urine sample:
water and spiked urine sample: 100 mM NH4OAc buﬀer solution (adjusted to pH 4 with
1% formic acid) were examined (total solution volume of 2 mL) and applied to the
Biotage Isolute supported liquid extraction (SLE)+ 2 mL column under vacuum and let to
sit for 5 min. Next, two washes of 2 mL dichloromethane (Acros Organics) under gravity
were applied to the SLE+ column and let sit for two minutes after each wash. Then, a
vacuum was applied to the SLE+ column eluting the dichloromethane, which was dried
down under nitrogen gas and reconstituted with 10% methanol. Finally, 10 µL of this
urine extracted sample was used into the formation of the SERS solution mentioned in
the above paragraph for analysis.
3.3.4. Instrumentation
The gold nanoparticles were characterized via ultraviolet-visible absorbance
(Varian Cary 100 Bio UV–visible spectrophotometer) and dynamic light scattering
(Malvern Zetasizer Nano). In addition to the nanoparticle size, the zeta potential of the
gold nanoparticles was measured using a Malvern Zetasizer Nano. The SERS solution
was transferred to a quartz suprasil cuvette (Hellma Analytics) and analyzed using a
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Perkin Elmer Raman Station 400F (bench top model) with a 785 nm laser at 100 mW
power with a resolution of 4 cm-1 (FWHM) for 5 scans with 4 s of laser exposure or to a
Thermo Scientiﬁc First Defender RM (portable) with a 785 nm laser at high power (250
mW) and a resolution of 7–10.5 cm-1 (FWHM). All samples were run in triplicate and
used to calculate limit of detection.
3.4 Results and discussion
In this study, four structurally similar JWH synthetic cannabinoids (JWH-018,
JWH-073, JWH-081, and JWH-122) were examined. The purpose of this work was to
determine if SERS was capable of diﬀerentiation of 4 structurally similar synthetic
cannabinoids at toxicological concentrations. This work is divided into four parts. Part
one focused on the gold nanoparticle synthesis used for SERS analysis. Part two focused
on the evaluation of chloride, sulfate, and nitrate salts to determine the optimal
aggregating agent concentration to detect the four synthetic cannabinoids examined. Part
three assessed the use of a portable Raman spectrometer in our SERS method, comparing
to our bench top results from part two. Part four looked into the use of SERS for the
toxicological screening of spiked urine samples. To our knowledge, this is the ﬁrst report
in the literature involving SERS analysis of these compounds.
3.4.1. Gold nanoparticle synthesis
The gold nanoparticles used in this study were created using a citrate reduction
method similar to Doctor et al.44 The reaction was deemed complete when the
tetrachloroauric (III) acid trihydrate solution changed from a yellow to a ﬁnal wine red
color following the addition of the sodium citrate. The resultant nanoparticles were
spherical in shape and ranged in size from 10 nm to 100 nm in diameter with an average
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size of 24.5±4.7 nm, and a zeta potential of −32.5±1.5 mV. The UV–VIS peak
absorbance was 521±1.7 nm (Figure 8a–c). The peak absorption and size distribution was
similar to previous results obtained by Doctor et al.45 and size distribution was similar to
previous results obtained by Doctor et al.44
(a)

(b)

(c)

Figure 8: Characterization of synthesized nanoparticles (a) UV-VIS absorption spectra;
(b) size distribution; (c) zeta potential distribution
3.4.2. Aggregating agent evaluation
In the previous work in this laboratory, chloride salts at various concentrations
were examined to determine the optimal method for gold nanoparticle aggregation and
SERS detection of benzodiazepines. Overall it was determined that a concentration of
0.0167 M MgCl2 produced the optimal sensitivity.44 In this work, a similar set of chlorate
salts as well as diﬀerent salts, such as sulfates and a nitrate, were examined to determine
their eﬀect on nanoparticle aggregation and its associated enhancements to the Raman
signal for the cannabinoids.
The cannabinoid samples were prepared for analysis as follows: 980 µL of the
nanoparticle solution was mixed with 10 µL of a select aggregating agent stock solution
and vortexed for 30 s. Next, 10 µL of the drug stock standard solution was added and
vortexed for 30 s, then placed in a cuvette for analysis by the Raman spectrometer. The
ﬁnal concentration of the analyzed samples were as follows: 0.05 mM HAuCl 4, 0.0167 M
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of aggregating agent, and between 2.5–2000 ng/ mL of the synthetic cannabinoid. Seven
diﬀerent aggregating agents were examined including MgCl2, CaCl2, NaCl, and KCl as
well as MgSO4, Na2SO4 and KNO3. The aggregating agent concentration was set at
0.0167 M due to results of optimized concentrations from previous studies and to limit
the amount of variables at the start of this study. Of the seven aggregating agents, only
MgCl2, CaCl2, and MgSO2 produced nanoparticle aggregation (a change from a red to a
grey solution) with subsequent Raman enhancement at this concentration (Figure 9).

Figure 9: Raman spectra of JWH-073 via the addition of MgCl2 (top), CaCl2 (middle) and
MgSO4 (bottom) at 250 ng/mL.
Figure 7 shows the Raman spectrum of each compound with 0.0167 M MgCl2 as
the aggregating agent. A prominent peak in each spectrum was used to establish the
slope, correlation coeﬃcient, and limit of detection (LOD) for each compound.
Compared to CaCl2 and MgSO4, MgCl2 produced the greatest sensitivity and lowest LOD
for all four synthetic cannabinoids (Table 1). For three out of the four JWH compounds,
MgCl2 produced more than a tenfold lower limit of detection. Based upon the above
parameters, it was determined that the best aggregating agent to use was MgCl2.
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It is notable that each compound produced a unique and identiﬁable Raman
spectrum that could be distinguished from the others (Figure 10). JWH-018 and JWH073 are similar in chemical structure, only varying in the length of the alkyl chain oﬀ the
nitrogen and have similar Raman spectrum. Yet, there are a few diﬀerences. Firstly,
JWH- 018 has an additional peak at 700 cm-1 not seen in JWH-073. Second, there are
diﬀerences in the peak locations near 1396 cm-1 and 1574 cm-1 producing a shift of 4 cm-1
(to 1392 cm-1 and 1578 cm-1) in the Raman spectra of JWH-018. Lastly, JWH-073
contains additional spectral peaks at and below 650 cm-1.

Figure 10: The Raman spectrum produced from JWH-018, JWH-073, JWH-081, and
JWH-122 using 0.0167M MgCl2. The indicated peak was used to determine the LOD of
each compound.
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Dynamic
Sensitivity
R2
Standard Calculated
Range
(Intensity/
Deviation
LOD
(ng/mL)
Concentration)
(ng/ml)
JWHMgCl2
2.5-250
31
0.99
5.3x102
51
018
CaCl2
25-500
8.7
0.92
2.4x102
84
2
MgSO4
2.5-500
2.3
0.96
2.2x10
2.8x102
2
JWHMgCl2
25-500
9.6
0.99
1.8x10
56
2
073
CaCl2
25-250
1.8
0.73
1.5x10
2.5x102
MgSO4
25-1000
0.36
0.91
1.2x102
9.9x102
3
JWHMgCl2
2.5-250
2.9
0.90
1.3x10
18
081
CaCl2
100-1000
0.5
0.98
64
3.8x102
MgSO4
2.5-1000
0.24
0.95
61
7.7x102
JWHMgCl2
2.5-250
3.4
0.99
68
60
2
122
CaCl2
25-500
2.5
0.99
2.0x10
2.3x102
MgSO4
25-500
0.05
0.22
72
4.3x103
Table 1: A comparison of the effect of 0.0167M MgCl2, CaCl2, and MgSO4 when used as
aggregating agents for the detection of JWH-018, JWH-073, JWH-081, and JWH-122.
Drug

Aggregating
agent

3.4.3. MgCl2 optimization
Further analysis was used to determine the eﬀect of variation in the MgCl 2
concentration on sensitivity (Table 2). Three diﬀerent concentrations of MgCl 2 were
examined for use as aggregating agents: 0.00835 M, 0.00167 M, and 0.0334 M. These
solutions were combined with 2.5–2000 ng/mL of each synthetic cannabinoid and
analyzed. To determine the LOD, the same spectral peaks used for part 1 were used for
part 2. For all four compounds, the 0.0167 M concentration produced the highest slope,
best linear correlation (R2 value), and lowest LOD.
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Drug

MgCl2
Concentration
(M)

Dynamic
Range
(ng/mL)

Sensitivity
(Intensity/
Concentration)

R2

Standard Calculated
Deviation
LOD
(ng/ml)

0.00835
25-500
11
0.88
2.5x102
72
2
0.0167
2.5-250
31
0.99 5.3x10
51
2
0.0334
25-500
3.6
0.97 3.3x10
2.8x102
JWH0.00835
50-1000
1.5
0.98 1.2x102
2.4x102
073
0.0167
25-500
9.6
0.99 1.8x102
56
0.0334
2.5-1000
1.9
0.97
88
1.4x102
JWH0.00835
25-500
5.1
0.97 2.1x102
1.3x102
081
0.0167
2.5-250
2.9
0.90 1.3x103
18
2
0.0334
2.5-500
1.8
0.98 2.6x10
4.3x102
2
JWH0.00835
2.5-250
3.8
0.95 1.1x10
90
122
0.0167
2.5-250
3.4
0.99
68
60
0.0334
25-500
0.65
0.92
35
1.6x102
Table 2: A comparison of 0.00835M, 0.0167M, and 0.0334M MgCl2 used to determine
the optimal aggregating agent concentration for the detection of JWH-018, JWH-073,
JWH-081, and JWH-122.
JWH018

3.4.4. Bench top Raman vs. portable Raman comparison
After the completion of optimization of the SERS method for the detection of four
diﬀerent synthetic cannabinoid compounds, a second analysis was preformed using a
portable Raman spectrometer to determine if similar results could be obtained. There are
a few diﬀerences between the two Raman instruments, such laser power, instrument
resolution, and scan settings varied. The Perkin Elmer Raman (bench top model) has a
100 mW laser with a resolution of 4 cm-1 (FWHM) while the Thermo Scientiﬁc First
Defender RM (portable) used a laser at a high power setting of 250 mW with a resolution
of 7–10.5 cm-1 (FWHM). For the benchtop system, each sample was scanned 5 times
with 4 s exposure time, while for the portable system, the number of scans and the
exposure time was varied based on input signal. The results from the portable Raman
spectrometer is shown Table 3. In addition to the 3 diﬀerent MgCl2 concentrations
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previously tested on the bench top model, 0.0125 M and 0.025 M MgCl2 were also
examined to further determine the optimal MgCl2 concentration for our SERS method.
The concentration of the gold nanoparticle solution and the synthetic cannabinoid
concentrations were the same as before.
Drug

MgCl2
Concentration

Dynamic
Range
(ng/mL)

Sensitivity
(Intensity/
Concentration)

R2

Standard Calculated
Deviation
LOD
(ng/ml)

0.00835
2.5-100
0.013
0.86
0.027
63
0.0125
2.5-100
0.0009
0.92
0.0007
18
0.0167
2.5-250
0.003
0.97
0.026
2.6x102
0.025
25-500
0.0002
0.94
0.024
3.6x102
0.0334
2.5-250
0.005
0.86
0.006
34
0.00835
25-500
0.0001
0.93
0.028
8.4x102
JWH0.0125
2.5-100
0.0003
0.87
0.01
1.0x102
073
0.0167
25-500
0.00005
0.98
0.012
7.1x102
0.025
2.5-250
0.0001
0.79
0.012
3.5x102
0.0334
2.5-250
0.0007
0.94
0.012
51
0.00835
2.5-500
0.0001
0.97
0.036
1.1x103
JWH0.0125
25-250
0.0002
0.85
0.087
1.3x103
081
0.0167
2.5-500
0.0002
0.89
0.047
7.0x102
0.025
25-250
0.0002
0.99
0.047
7.1x102
0.0334
2.5-500
0.0002
0.88
0.002
34
0.00835
10-250
0.0002
0.88
0.022
3.4x102
JWH0.0125
5-250
0.0002
0.72
0.047
7.0x102
122
0.0167
2.5-100
0.0003
0.93
0.0066
66
0.025
2.5-100
0.0003
0.78
0.0042
42
0.0334
2.5-1000
0.00005
0.96
0.010
6.3x102
Table 3: A comparison of 0.00835M, 0.0125M, 0.0167M, 0.025M and 0.0334M MgCl2
used to determine the optimal aggregating agent concentration for the detection of JWH018, JWH-073, JWH-081, and JWH-122 using the portable Raman spectrometer.
JWH018

Upon analysis of the portable Raman data, the optimal concentration of MgCl2
aggregation used in the Raman analysis of each JWH compound varied. However, for 3
out of the 4 JWH synthetic cannabinoids, a concentration higher than 0.0167 M MgCl 2
produced the lowest calculated LOD, with the exception that 0.0125 M was optimal for
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JWH-018. For JWH-073 and JWH-081, the 0.0334 M MgCl2 produced the lowest
sensitivity and calculated LOD. These results may simply be the result of diﬀerences in
optical conﬁgurations and laser power. Therefore, we suggest that users should optimize
nanoparticle and aggregating agent concentrations when using diﬀerent instrument
conﬁgurations.
To further assess the capability of the portable Raman system, a comparison of
the library spectrum of the JWH-018, JWH-073, JWH081, and JWH-122 was made with
the SERS spectrum obtained from that same instrument (Figure 11). The main diﬀerences
in the library spectra are seen near 500 cm-1 and in between 1500 and 1800 cm-1. JWH018 and JWH-073 are nearly identical but can be resolved based upon the additional peak
seen at 1288 cm-1 and double peaks near 1600 cm-1 seen in the JWH-073 spectrum. For
JWH-081 and JWH-122 the bench top, portable, and library spectra are similar. For
JWH-018 and JWH-073 benchtop spectra varies slightly between the portable and library
spectra in peak intensity and resolution. However, for all compounds analyzed with the
portable Raman, the library search feature identiﬁed the correct compound, indicating the
speciﬁcity of the analysis and also demonstrating that obtained SERS spectra for these
compounds is very similar to that obtained from drug powders.
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Figure 11: A comparison of the benchtop (top), portable (middle), and library (bottom)
Raman spectra of JWH-018 (100 ng/mL), JWH-073 (250 ng/mL), JWH-081 (100
ng/mL), and JWH-122 (100 ng/mL) with 0.0167M MgCl2 as an aggregating agent.
3.4.5. Spiked urine sample
To examine the capability to the SERS method to screen biological samples, an
analysis was performed on a set of spiked urine samples containing JWH-018, JWH-073,
JWH-081, or JWH-122 using supported liquid extraction (SLE). SLE is a quick
extraction method that takes under 20 min and uses a silica based solid support to
caputure the aqueous phase, while still permitting later transfer into an organic solvent.45
For this analysis, urine samples were diluted 1:1 with water or diluted 1:1 with buﬀer
(100 mM NH4OAc buﬀer solution adjusted to pH 4 with 1% formic acid). After dilution,
the urine column. Two 5 min washes of dichloromethane were performed and the sample
was eluted under vacuum. This solution was then evaporated to dryness under nitrogen
gas and reconstituted with 10% methanol into 4 mL total volume. Then, 10 µL of
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extracted sample was added to the sample analysis solution containing: 0.05 mM HAuCl4
and 0.0334 M of aggregating agent.
A comparison of the Raman spectra of JWH-018 obtained involving urine
samples analyzed after or without extraction prior to analysis (Figure 12). All spiked
urine samples were analyzed at the concentration of 500 ng/mL. These samples were
analyzed with the First Defender RM portable Raman system. Based these results, only
urine samples diluted with water produced a usable spectra. The recovery of JWH-018
was 86%. This result demonstrates that the SLE can be used as an extraction method for
the detection of JWH synthetic cannabinoids.

Figure 12: The Raman spectrum of a JWH-018 standard (1000 ng/mL) using from the
optimized SERS method (1), a spiked urine sample (500 ng/mL) with 1:1 water dilution
(2), spiked urine sample (500 ng/mL) with 1:1 ammonium acetate buffer dilution
(3), spiked urine sample (2000 ng/mL) without any extraction (yellow), along with
background sample (4) and pure urine (5).
3.5. Conclusion
This paper demonstrates the application of surface enhanced Raman spectroscopy
in the detection of synthetic cannabinoids. An analysis of chloride, sulfate, and nitrate
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salts as aggregating agents were conducted. The optimal SERS procedure involves the
mixing of an unknown sample with gold nanoparticles and 0.0167 M MgCl2 as an
aggregating agent. This new procedure can easily distinguish 4 structurally similar
cannabinoids with LODs ranging from 18 to 60 ng/mL. For determination of these
compounds in urine, a quick extraction method using supported liquid extraction was
suﬃcient for detection. Overall this method is quick, sensitive and can be used in
combination with portable instrumentation. Unlike standard immunoassays, the
procedure provides identiﬁable spectra which can assist the analyst in downstream
conﬁrmation by mass spectrometry. It should prove to be a powerful tool for screening
toxicological samples.
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4. AN EVALUATION OF MONOVALENT, DIVALENT, AND TRIVALENT
CATIONS FOR THE SERS ANALYSIS OF SYNTHETIC CANNABINOIDS
Reproduced from Mostowtt T, Munoz J, McCord B. An evaluation of monovalent,
divalent, and trivalent cations as aggregating agents for surface enhanced Raman
spectroscopy (SERS) analysis of synthetic cannabinoids. Analyst. 2019 Mar 1;164: 396402 with permission from the Royal Society of Chemistry.
4.1 Abstract
In this study monovalent, divalent, and trivalent chloride, sulfate and nitrate salts
were examined to determine the critical coagulation concentration (CCC) for each salt
and its corresponding effect on detection limits for SERS analysis of cannabinoid
extracts. The CCC of each salt was determined using UV-vis, particle size and zeta
potential measurements. The results demonstrated that the divalent and trivalent cations
produce a lower CCC when compared to monovalent cations. The data indicate the effect
that cation valence has on nanoparticle destabilization. This information is essential
because it permits the user to develop optimal conditions for aggregation of salts used in
SERS. Tests were then performed to determine the best conditions for SERS detection of
a small set of cannabinoids with naphthyl indole moieties. The results demonstrate the
importance of salt concentration for colloid aggregation and illustrate the effect of
aggregation on sensitivity for the SERS experiment.
4.2 Introduction
A critical feature of surface enhanced Raman spectroscopy (SERS) is the use of a
metal substrate, which can be in the form of roughened metal surfaces or colloidal metal
nanoparticles, typically produced from coinage metals. A variety of methods have been
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developed to create nanocolloids in various shapes including spheres, rods, and stars,
using several different reducing agents. One of the most common methods of producing
gold nanoparticles utilizes sodium citrate as the reducing agent for gold chloride salts. A
significant amount of research has been conducted to develop theories on the nucleation,
growth, and formation of stable, polydisperse gold nanoparticles.29,31,71-73
For optimal SERS enhancement, it is common to add a chloride salt to the
colloidal metal nanoparticle solution. This destabilizes the nanoparticles creating ‘hot
spots’ which provide signal enhancement due to localized enhancement of the electric
field.25 Multiple studies have demonstrated that a red shift occurs in the UV-Vis
absorption of the nanoparticles following the addition of an aggregating agent. 31,33, 74
Additionally, this process commonly results in a decrease in the zeta potential of the
nanoparticle.33,34 A study by Burns et al. examined the relationship between color change
and the type of salt, ionic strength, and its associated Debye length. 34 Their suggestion
was that cation adsorption into the stern layer of the nanoparticle played a major role in
this process due to a net reduction of nanoparticle surface charge. This process reduced
the repulsion between nanoparticles permitting closer interparticle distances and allowing
interactions between particles that resulted in color change. Ionic strength and Debye
length were not thought to be factors. It is generally postulated that the anion of the
aggregating agent has a major effect on SERS enhancement by displacing the reducing
agent surrounding the nanoparticle. This process is known as the chloride ion effect.25
In previous work in our laboratory we have demonstrated that concentrations as
low as 0.5 ng mL-1 of benzodiazepines can be detected in urine using supported liquid
extraction followed by SERS.45 Interestingly, this work also demonstrated that sensitivity
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for the SERS technique varied greatly depending on the nature of the salt used for
nanoparticle aggregation, and more particularly on the type of cation as predicted by
Burns et al. Thus, the focus of this study was to gain a better understanding of the process
of gold nanoparticle aggregation via salt through experiments involving absorption and
zeta potential, as well as measuring their effect on SERS enhancements. To perform these
experiments, we examined nine different synthetic cannabinoids using a portable Raman
spectrometer. These compounds, also known as novel psychoactive substances, provide
an interesting test set for optimizing SERS analysis through aggregation, due to the
controlled minor variations in structure from one form of the molecule to the next (Figure
13). These changes are typically performed to maintain psychotropic effects yet produce
sufficient changes in the molecules to avoid legal scheduling.
It should be noted that there has been a resurgence of interest in recent years on
the use of SERS in forensic applications including biological fluids,75 trace evidence,76,77
gunshot residue,75 explosives,78 as well as drug analysis and toxicology.45,79-85 The
various designer drugs that have been examined include JWH-018, JWH-073, JWH-081,
JWH-122, 5F-PB-22, α-PVP, and AMB-FUBINACA.49,50, 86-88 The SERS procedure
permits rapid analysis at high sensitivity and does not require recognition elements for
specificity as does immunoassay based techniques. This can be particularly important in
the analysis of novel designer cannabinoids, where structures of illicit substances are
constantly changing. These structural variants often lack sufficient cross reactivity with
standard immunological testing methods but can be differentiated by SERS
techniques.15,89 Therefore, an additional and important goal of this paper is to define an
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optimized procedure for analysis of these drugs using colloidal nanoparticles and
aggregating agents.

JWH-122

JWH-175
JWH-147

MAM-2201

AM-2201
JWH-030

Figure 13: The chemical structures of the nine different synthetic cannabinoids examined
in this study.
4.3 Experimental
4.3.1 Materials used
Preparation of the gold nanoparticle colloids was based on studies previously
conducted by Doctor et al., Deriu et al., and Mostowtt et al.44,86,87 100 mL gold
nanoparticle solutions were prepared reducing tetrachloroauric (iii) acid trihydrate (Acros
Organics, LOT#A0354619) with 4 mL of a 1% by weight solution of trisodium citrate
dihydrate (Fisher Scientific, LOT #091236) at pH 5.
Monovalent (K+ and Na+), divalent (Ca2+ and Mg2+), and trivalent (Al3+) chlorate,
nitrate, and sulfate salts were studied as aggregating agents for the SERS analysis of
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synthetic cannabinoids. The monovalent cations in this study included KCl (Spectrum),
NaCl (Sigma-Aldrich), K2SO4 (Fisher Scientific), Na2SO4 (Spectrum), NaNO3 (Fisher
Scientific), and KNO3 (Fisher Scientific). The divalent cations examined include MgCl2
(Fisher Scientific), CaCl2 (Fisher Scientific), MgSO4 (Fisher Scientific), CaSO4 (SigmaAldrich), Mg(NO3)2 (Fisher Scientific), and Ca(NO3)2 (Fisher Scientific). The trivalent
cations included AlCl3, (Fisher Scientific), Al2(SO4)3 (Fisher Scientific), and Al(NO3)3
(Fisher Scientific).
Synthetic cannabinoid standards (in powder) of JWH-073 (LOT #1293.1B1.2)
and JWH-081 (LOT #1505.1B1.1) were obtained from Lipomed AG and JWH-030 (LOT
#0443548-16), JWH-147 (LOT #0444979-9), and MAM-2201 (LOT #0483939-13) were
obtained from Cayman Chemical. DEA exempt preparation of (mg mL−1 in methanol)
JWH-018 (LOT #0448916-52), JWH-122 (LOT #0497508-1, JWH-175 (LOT #045046714), and AM-2201 (LOT #0499457-1) were obtained from Cayman Chemical. All the
above standards were used to create stock standard solutions at concentrations ranging
from 25–20000 ng mL-1 in a 10% methanol (0.02 M) solution.
4.3.2 UV-vis spectroscopy
For this procedure 980 μL of the gold nanoparticle solution was placed into a
quartz Suprasil® cuvette (Hellma Analytics). Then, a select amount of aggregating agent
solution was titrated into the cuvette, vortexed, and analyzed via a UV-visible
spectrophotometer. The initial stock concentrations for the aggregating agents were as
follows: 0.84 M for monovalent cation salts and 0.05 M for divalent and trivalent salts.
The amount of aggregating agent solution titrated to the gold nanoparticles varied from
10–100 μL (in increments of 10 μL) for monovalent salts and 5–50 μL (in increments of
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5 μL) for divalent and trivalent salts. The calculated concentration of the aggregating
agent in the overall solution was used for data analysis and interpretation of UV-vis
results, as well as SERS analysis. All samples were run in triplicate using three
nanoparticle solutions that were made on three different days.
4.3.3 Zetasizer study
Analysis was conducted on the nanoparticle and aggregating agent interaction via
dynamic light scattering at pH 5. The change in nanoparticle size and zeta potential was
measured with three different concentrations for each aggregating agent based upon
results obtained from the UV-vis study. The results show that a red shift occurs in the
absorbance of the nanoparticles with increasing aggregating agent concentration (Table
4). Three concentrations were determined: the initial aggregating agent concentration
titrated in the UV-vis study, the concentration at which a color change of the nanoparticle
solution occurred from red to purple, and the concentration at which a color change
occurred from purple to grey/clear color. The stock solution concentration of each
aggregating agent varied based upon the aggregating agent concentration needed from
Table 4. For example, to have a final concentration of 0.048 M NaCl in the SERS
nanoparticle solution, a stock solution of 4.8 M NaCl was made. The stock concentrations
for the aggregating agents ranged from 0.025 M to 4.8 M. Not all aggregating agents
from the UV-vis study were used in this part of the study due to poor solubility in water.
The aggregating agents not examined included: K2SO4, Na2SO4, NaNO3, KNO3, CaSO4,
Mg(NO3)2, and Ca(NO3)2. The aggregating agents examined were NaCl, CaCl2, MgCl2,
AlCl3, NaNO3, Ca(NO3)2, Mg(NO3)2, Al(NO3)3, Mg(SO4)2, and Al2(SO4)3.
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Aggregating Agent
KCl and NaCl
CaCl2 and MgCl2

(A)
0.0084M
0.00025M

(B)
0.033M
0.00075M

(C)
0.048M
0.0015M

AlCl3

0.00025M

0.0005M

0.0012M

NaNO3

0.0084M

0.041M

0.055M

Ca(NO3)2, Mg(NO3)2, and MgSO4

0.00025M

0.001M

0.0015M

Al(NO3)3 and Al2(SO4)3

0.00025M

0.0005M

0.001M

Table 4: (A) Initial concentration of aggregating agents examined, (B) Aggregating agent
concentration at which initial color change occurred from red to purple, and (C)
Aggregating agent concentration at which initial color change occurred from purple to
grey/clear color.
In these experiments, 980 μL of the gold nanoparticle solution was placed into a
glass vial (Fisher scientific) followed by 10 μL of the aggregating agent, vortexed, placed
into a polystyrene cuvette and analyzed to determine nanoparticle size. Then, the same
solution was transferred to a disposable capillary cell for zeta potential analysis. In a
second part of this study 10 μL of a 10% methanol (0.02 M) solution was added to the
nanoparticle solution after the addition of the aggregating agent (SERS optimization
negative control), vortexed, and analyzed for change in nanoparticle size and zeta
potential. This part of the study was conducted to show that the 10% methanol (0.02 M)
solution does not affect the nanoparticle and aggregating agent interaction. All samples
were run in triplicate using three nanoparticle solutions made on different days.
The size of the nanoparticles was analyzed using a 4 mL (10 mm thickness)
polystyrene cuvette (Sarstedt) via dynamic light scattering based upon the theory that
particles move by Brownian Motion. The detector was placed at 173° scattering angle,
measuring the scattered light via backscatter detection. The relationship between particle
size and Brownian motion can be determined by the Stokes–Einstein equation
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𝐷𝑇 =

𝑘𝑏 𝑇
3𝜋ɳ𝑑

(5)

where DT is the diffusion coefficient, η is the viscosity of the fluid, T is the temperature,
kb is the Boltzmann constant, and d is the particle's diameter.30 The instrument measures
the correlation of the diffusion of the nanoparticles over time to determine the diffusion
coefficient, using the Stokes–Einstein equation to determine the size of the nanoparticles.
The rate of decay of the correlation is related to the nanoparticle size. The smaller the
nanoparticle, the faster the rate of decay.
The zeta potential of the nanoparticles was determined using a DTS1070
disposable folded capillary cell (Malvern) measuring the electrophoretic mobility of the
nanoparticles and converted to zeta potential via the Henry equation

𝑈𝐸 =

2𝜀𝑧𝑓(𝑘𝑎)
3ɳ

(6)

where UE is the electrophoretic mobility, η is the viscosity of the fluid, z is the zeta
potential, ε is the dielectric constant, f(ka) is Henry's function.31 An electric field is
applied to the nanoparticle solution, dispersing the particles to the sign opposite of their
charge and measures the scattered light at a 13° from the incident beam. This in
combination with the reference beam produces a fluctuation in the signal intensity over
time that is proportional to the speed of the nanoparticle and used to determine the
electrophoretic mobility.
4.3.4 SERS optimization
The results from the UV-vis study determined the aggregating concentration used
for each salt in the SERS analysis of the synthetic cannabinoids. SERs analysis was
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performed using the following procedure.86 First, 980 μL of the gold nanoparticle
solution was placed in a clear 2 mL glass vial (Fisher Scientific) followed by 10 μL of a
select aggregating agent solution and vortexed for 30 seconds. Then, 10 μL of the drug
stock standard solution was added to the 2 mL sample vial and vortexed for 30 seconds.
The final concentration of each component in the gold nanoparticle solution was as
follows: 0.05 mM HAuCl4, between 0.001–0.055 M of aggregating agent, and between
2.5–2000 ng mL-1 of each synthetic cannabinoid in 0.02 M methanol. Each sample was
run in triplicate. A culmination of all the data was used to calculate the limit of detection
for each synthetic cannabinoid.
4.3.5 Instrumentation
The nanoparticle and aggregating agent interaction was studied using a Varian
Cary 100 Bio UV-visible spectrophotometer (absorbance) and Malvern Zetasizer Nano
ZS (nanoparticle size and zeta potential) were used in these experiments. The SERS
solutions were transferred to a quartz Suprasil® cuvette (Hellma Analytics) and analyzed
using a Thermo Scientific FirstDefenderRM (portable) with a 785 nm laser at high power
(250 mW) with a resolution of 7 to 10.5 cm-1 (FWHM).
4.4 Results and discussion
In this study, nine different synthetic cannabinoids (JWH-018, JWH-030, JWH073, JWH-081, JWH-122, JWH-147, JWH-175, AM-2201, and MAM-2201 were
examined in order to gain a better understanding of the nanoparticle, aggregating agent,
and drug interaction to produce the achieved SERS enhancement as well as optimization
of the detection of synthetic cannabinoids. This study is divided into two parts. The first
part examines how different aggregating agents within varying concentrations affect the
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gold nanoparticle destabilization. The second part evaluates the effect of monovalent,
divalent, and trivalent chloride, sulfate, and nitrate salts to determine the optimal
aggregating agent concentration to detect the nine synthetic cannabinoids examined. The
objective of this study is to explain why certain salts work better than others for the
detection of synthetic cannabinoids in solution.
The gold nanoparticles were created via a citrate reduction method, similar to
Doctor et al.44 The UV-VIS peak absorbance was 521 ± 0.7 nm. The peak absorption and
size distribution were similar to previous results obtained by Mostowtt et al. and Doctor
et al.44,86
4.4.1 Aggregating agent optimization
In the first part of this study, 15 different aggregating agents were examined
including monovalent, divalent, and trivalent chloride, sulfate, and nitrate salts. The goal
of this part of the study was to determine the concentration at which nanoparticle color
change and aggregation (a change from red to grey/clear solution color) occurred for each
salt, while gaining a better understanding of the mechanism by which the cation and
anion of the aggregating agent interact with the nanoparticles to produce SERS
enhancement.
Kim et al. examined the effect of gold nanoparticle aggregation following the
addition of benzyl mercaptan as the aggregating agent over a period of 2 hours. They
found that as time passed the UV-vis spectrum of the nanoparticles red shifted and
decreased the original plasmon band at 520 nm, and a new plasmon band at
approximately 720 nm appeared.33 In addition, Kim et al. studied the change in the zeta
potential with the addition of benzyl mercaptan. The results showed a decrease in the zeta
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potential of the gold nanoparticles after the addition of benzyl mercaptan. Two hours
following the addition of the benzyl mercaptan, the zeta potential continued to decrease.8
The results of the UV-vis and Zetasizer study indicate that as an aggregating agent is
added to the nanoparticle solution the nanoparticles destabilize and come closer together
resulting in a decrease in the zeta potential.
In a study by Bell et al., the UV spectra of gold colloidal nanoparticles of various
sizes following the addition of MgSO4 was examined to determine an optimal SERS
method to detect thiophenol in solution.74 For the 46 nm gold colloids, as the amount of
MgSO4 increased from 0.00055 mol dm-3 to 0.011 mol dm-3 the absorbance of the
original plasmon band decreased and an additional band appeared at 640 nm with shifts
to 800 nm at higher MgSO4 concentrations. For the 30 nm gold colloids, as 0.0033 mol
dm-3 MgSO4 was added to the colloid solution, an additional band at 800 nm appeared.
As the MgSO4 concentration increased from 0.0033 mol dm-3 to 0.024 mol dm-3, the
absorbance of the original plasmon band and the new plasmon band decreased. Bell et al.
considered this reaching a ‘fully aggregated’ plateau.74 The authors attributed the effect
of the MgSO4 on the gold colloid solution to the formation of gold colloid aggregates.
In this study, the aggregating agent was titrated in varying ratios with the gold
nanoparticle solution. The concentration at which any color change occurred was noted
(Table 1) and analyzed via UV-visible spectroscopy to access the change in absorbance
of the nanoparticle solution as the salt concentration increases (Figure 14). The
concentration of the aggregating agent at the color transition was calculated based upon
the amount of salt added to the nanoparticle solution. The results obtained in this study
agreed with the previous work mentioned above. For all the salts examined, as the
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concentration increased, the absorbance at 521 nm decreased and shifted to a higher
wavelength. In addition, as the salt concentrations increased above the values noted in
Table 1 Row C, a decrease in the absorbance of the original and red shifted plasmon band
was seen. A ‘fully aggregated’ plateau was achieved. Therefore, at concentrations above
Table 1 Row C for each salt, SERS enhancement may be less effective for the gold
nanoparticle solutions formed in this study.

Figure 14: Characterization of the changes in absorption of the gold nanoparticle solution
as concentration of NaNO3 increases.
Using the data collected, the change in maximum absorbance at 521 nm was
plotted versus the change in concentration. When comparing monovalent, divalent, and
trivalent cations, a higher concentration of the monovalent cations was needed to achieve
color change compared to the divalent and trivalent cations (Figure 15). However, when
comparing the anions of each monovalent, divalent, and trivalent cation, no major
difference in the red shift of the surface plasmon band was observed (Figure 16). These
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results demonstrate the importance of the cation in the color change and aggregation
process.

Figure 15: Comparing changes in absorption of the gold nanoparticle solution as
concentration of various chloride salts increase.

Figure 16: Characterization of the changes in absorption of the nanoparticles as
concentration of the cation increases.
Burns et al. investigated the effect of ionic strength on gold nanoparticle
aggregation and how this relates to the visible color change seen, from red to purple, after
the addition of various aggregating agents. In their study, the ionic strength, activity
coefficient and Debye length (particle-to-particle mean distance) were calculated.34 From
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their calculations, the higher the ionic strength (i.e. the higher the salt concentration), the
lower the Debye length between nanoparticles, resulting in a stronger surface plasmon
interaction between nanoparticles.34 The divalent cations examined produced a color
change at a lower concentration than the monovalent cations and thus had a larger
calculated Debye length. Therefore, the color change seen after the addition of the
aggregating agent may not be related to the calculated Debye length between
nanoparticles, but instead the result of the cation adsorption to the surface of the
nanoparticles which permits closer association.34 However, the authors did not ex4mine
the effect of higher concentrations of salts on aggregation.
In general, the work of Burns et al. indicated that the cation of the aggregating
agent influences nanoparticle destabilization. Burns et al. showed a change in the zeta
potential from negative to positive between the beginning and the titration end point of
the aggregating agent.34 Their results show that the destabilization of the nanoparticles
through the use of an aggregating agent does not just displace the negatively charged
reducing agent, in this case citrate, with the anion of the aggregating agent salt. It also
shows that the cation assists in the destabilization of the nanoparticles. In our results, we
examined a wider range of salt concentrations and showed that divalent cations also
produce aggregation at a lower salt concentration than the monovalent cations (Table 4
and Figure 15).
The presence of aggregation can be elucidated by studying the change in
nanoparticle size and zeta potential after the addition of aggregating agents. As the
aggregating agent was added to the nanoparticles, the distribution of the average
nanoparticle size changed (Table 5). The addition of the aggregating agent destabilizes
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the nanoparticle, reducing the electrostatic attraction between particles bringing them
closer together and producing aggregates.92,93 It is important to note that the Zetasizer
interprets aggregated nanoparticles as one larger nanoparticle. Due to this, the calculated
increases in average nanoparticle sizes indicate agglomeration. Thus, the sizes produced
indicate the effect of nanoparticle destabilization is not just closer interactions between
particles but the formation of aggregates (Figure 17).
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Figure 17: Characterization of the change in size (diameter) of the gold nanoparticles as
concentration of NaNO3 increases.
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Salt
Concentration

AuNP
AuNP
Size Avg Size Std
(nm)
Dev (nm)
27.7
6.7
51.9
14
130
51
130
18
41.5
4.3

None
0.0084M NaCl
0.033M NaCl
0.048M NaCl
0.00025M
CaCl2
0.00075M
CaCl2

Salt
Concentration

AuNP
Size Avg
(nm)
181

AuNP
Size Std
Dev (nm)
50

0.00025M
Mg(NO3)2

51.0

8.7

0.001M
Mg(NO3)2

126

29

0.0015M
Ca(NO3)2

132

48

0.0015M
Mg(NO3)2

154

54

138

18

45.5

3.9

0.00025M
MgCl2

31.1

5.8

0.00025M
Al(NO3)3

33.9

7.6

0.00075M
MgCl2

87.9

37

0.0005M
Al(NO3)3

186

31

0.0015M
MgCl2

164

44

0.001M
Al(NO )

45.1

7.9

0.00025M
AlCl3

56.1

12

0.00025M
MgSO4

148

35

0.0005M AlCl

46.5

11

0.001M
MgSO4

0.0012M AlCl3

129

24

0.0015M
MgSO4

209

77

0.0084M
NaNO3

44.0

9.8

0.00025M
Al2(SO4)3

35.8

12

188

31

143

39

0.055M NaNO3

198

53

0.0005M
Al2(SO4)3

0.001M
Ca(NO3)2

154

35

0.001M
Al2(SO4)3

175

27

0.001M CaCl

2

3

0.041M NaNO

3

3 3

Table 5: Characterization of the change in the average size (diameter) of the gold
nanoparticles as the salt concentration increases.
The effect of the addition of the aggregating agent is demonstrated in Figure 14,
which shows that as the aggregating agent was added to the nanoparticle solution, a shift
in the average size of the particles occurs. As the initial amount of salt is added to the
nanoparticles, the single nanoparticle size distribution peak splits into two peaks
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demonstrating the start of the aggregation process; however, at this stage no visible color
change has occurred. As the salt concentration increases to cause a color change from red
to purple, an increase in the number of destabilized nanoparticles is seen. Upon complete
aggregation, the nanoparticle solution turns to a grey/clear color and a single peak is
formed. This data demonstrates that the addition of aggregating agent not only
destabilizes the nanoparticles and alter the spectra, but it clearly induces the formation
aggregates, even at the earliest stages.
Another factor to consider is the effect of the aggregating agent on the zeta
potential of the nanoparticle (Table 6). For these nanoparticles, citrate stabilizes the gold
colloids and results in an overall negative zeta potential. In this study, the zeta potential
decreased as the salt concentration increased, indicating a reduction in charge, leading to
closer interactions between particles and thus aggregation. This result is consistent with
the nanoparticle size study. In general, nanoparticles are considered stable if the
nanoparticle solution has an average zeta potential value equal to or greater than the
average nanoparticle size. Destabilization occurs when the zeta potential is less than the
average nanoparticle size. In this study, the nanoparticle solution without the addition of
any aggregating agent had an average nanoparticle size of 27.7 ± 6.7 nm and an average
zeta potential of −35.9 ± 2.1 mV. When the recorded zeta potential (35.9 mV) is higher
than the size (27.7 nm), the nanoparticles in solution are considered stable. Comparing
the results following the addition of the aggregating agents at all the concentrations
examined, the nanoparticle size value was greater than that of the zeta potential and
aggregation occurred as shown in Figure 17.
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No MeOH Added

MeOH Added

Salt and
Concentration

Zeta Potential
Average (mV)

Zeta Potential
Average (mV)

None
0.0084M NaCl
0.033M NaCl
0.048M NaCl
0.00025M CaCl

-35.9

Zeta Potential
Standard Dev
(mV)
2.1

-35.1

3.8

-34.8
-46.4
-30.0
-30.5

5.8
4.9
7.2
1.8

-38.6
-52.9
-34.1
-31.9

2.6
6.2
3.1
1.8

0.00075M CaCl

-25.6

1.3

-24.3

0.8

0.001M CaCl

-18.7

0.7

-21.0

1.7

0.00025M MgCl

-34.6

2.2

-30.8

1.5

0.00075M MgCl

-26.7

1.1

-27.1

0.9

0.0015M MgCl

-22.3

1.0

-21.7

1.0

-36.2

4.3

-36.5

3.2

0.0005M AlCl

-32.7

4.1

-31.3

3.2

0.0012M AlCl

-18.3

3.3

-19.6

5.2

0.0084M NaNO3

-34.5

5.7

-38.8

1.4

0.041M NaNO3

-26.7

8.0

-36.9

5.3

0.055M NaNO3

-27.1

10

-31.1

1.9

0.00025M Ca(NO )2

-29.3

1.3

-31.7

1.8

0.00075M Ca(NO )2

-19.0

3.9

-21.1

1.2

0.0015M Ca(NO )2

-16.1

4.3

-13.6

1.2

0.00025M Mg(NO3)2

-28.9

1.4

-31.7

1.7

0.001M Mg(NO3)2

-21.8

1.5

-21.5

0.5

0.0015M Mg(NO3)2

-17.8

1.4

-19.2

0.8

0.00025M Al(NO3)3

-33.3

3.2

-41.1

1.2

0.0005M Al(NO3)3

-27.7

7.7

-35.2

1.7

0.001M Al(NO3)3

-12.4

4.3

-12.5

3.0

0.00025M MgSO

-29.5

2.6

-32.6

1.2

0.001M MgSO4

-21.7

1.1

-23.5

1.0

-13.7

1.9

-15.2

5.8

0.00025M Al2(SO4)3

-32.3

3.7

-39.7

2.0

0.0005M Al2(SO4)3

-16.9

3.2

-17.7

2.3

0.001M Al2(SO4)3

-6.9

6.3

-2.6

0.4

2
2

2
2
2

2

0.00025M AlCl

3

3
3

3
3

3

4

0.0015M MgSO

4

Zeta Potential
Standard Dev (mV)

Table 6: A comparison of the changes in the gold nanoparticle solution zeta potential
after the addition of chloride, sulfate and nitrate salts with and without the addition of 10
μL of 10% methanol (0.02 M) solution.
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To determine if the addition of methanol has any effect on the nanoparticle and
salt destabilization, a comparison of these results was performed with and without the
addition of 10 μL of 10% methanol (0.02 M). In our analytical method the synthetic
cannabinoids were dissolved and/or diluted in a 10% methanol (0.02 M) solution. The
results seen in Table 3, demonstrate that the addition of the 10% methanol (0.02 M)
solution had no effect on zeta potential.
A few studies investigating the effect of salts on aggregation reference the
Hofmeister series and how the values produced relate to the critical coagulation
concentration (CCC).35,36,94-98 The Hofmeister series organizes cations and anions
according to their ability to salt-out (kosmotropic) or salt-in (chaotropic) proteins. The
CCC is the concentration of the aggregating agent counterions needed to induce
destabilization of the nanoparticles at a demarcation between fast and slow
aggregation.35,36 A recent study by Tian et al. determined the CCC of nitrate salt
aggregating agents containing various alkali cations for montmorillonite nanoparticles
(negatively charged nanoparticles). They determined that larger alkali cations need a
lower concentration to reach the CCC compared to smaller alkali cations.96 Oncsik et al.
studied various salts of monovalent cations and anions of the Hofmeister series and their
effect on the CCC of polystyrene latex nanoparticles functionalized with sulfate
(negatively charged stern layer) or amidine (positively charged stern layer). For the
positively and negatively charged polystyrene latex nanoparticles, the more hydrated
cations and anions needed a higher concentration to reach the CCC. 35 Therefore, a higher
concentration of a strongly hydrated cation or anion should be needed to produce the
same end effect of nanoparticle destabilization.
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Pavlovic et al. studied the effects of various potassium monovalent, divalent,
trivalent, and tetravalent anions salts on of the aggregation of MgAl–NO3–LDH particles.
The monovalent anions followed the indirect Hofmeister series, except for HCO3-, which
achieved the CCC at the lowest concentration. In addition, the divalent, trivalent, and
tetravalent anions salts achieved the CCC at a lower concentration than the monovalent
anions. However, as the concentration of PO43-, Fe(CN)63-, and Fe(CN)64- increased, a
stabilization of the nanoparticles occurred, creating a second and third CCC, which could
be due to hydrophobic interactions, hydrogen bonding, or electrostatic interactions.37
Rouster et al. determined the critical coagulation ionic strength (CCIS) of similar
potassium salts on positively and negatively charged titania nanosheets. The CCIS relates
the ionic strength of the salt to the CCC. The charge of the titania nanosheets was created
by changing the pH. The result of the positively charged titania nanosheets agreed with
the results obtained by Pavlovic et al. The higher the valence of the anion, the lower the
concentration needed to reach the CCIS following the Schulze–Hardy rule. However, the
negatively charged titania nanosheets, followed the inverse the Schulze–Hardy rule.97
Our research study included an examination of monovalent and divalent anions as
well as monovalent, divalent, and trivalent cations. When comparing the chloride, sulfate,
and nitrate anions, the results showed a similar trend on the effect on nanoparticle size
and zeta potential (Tables 5 and 6). The cations examined in our study can be ranked
from strongly to weakly hydrated as follows: Al3+ > Mg2+ > Ca2+ > Na+. Yet, the cation
that produced the lowest CCC was Al3+ and the cation that produced the highest was Na+.
These results indicate that the destabilization produced by these cationic salts
follow an indirect Hofmeister series.96,97 Salts which keep negatively charged proteins
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stable also produce lower CCCs. These results are in accordance with the Derjaguin,
Landau, Verwey, and Overbeek (DLVO) theory which states that colloids in solution
stabilize due to van der Waals dispersion forces and Coulomb repulsions (electrostatic
interactions).25,98 In addition, the Schulze–Hardy rule states that the destabilization of the
nanoparticles is affected by the valence of the aggregating agent cation. A higher valence
will induce the CCC at a lower concentration.40 The results in our study agree with the
Schulze–Hardy rule. When comparing the various chloride salts examined in our study,
the higher charged cation, Al3+, reached the CCC at a lower salt concentration. In
addition, the study on the change in nanoparticle size and zeta potential demonstrated that
the type of cation used as the aggregating agent can affect the CCC of gold nanoparticles.
This is important to understand SERS enhancement. In the final portion of this study, the
ability to detect nine different synthetic cannabinoids via SERS was examined to
determine an optimal aggregating agent to use for further studies on biological samples.
4.4.2 SERS optimization
The aggregating agent concentrations used in this part of the study were the
concentrations indicated in Table 4, Row C. Initially, the SERS spectrum of the negative
controls were examined. The negative controls only contained the gold nanoparticles, an
aggregating agent, and 0.02 M of methanol (Figure 18). The SERS spectrum produced
resulted mainly from the background signal of the aggregating agents and varied with the
type of salt used.
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Figure 18: A comparison of the SERS spectrum of ten different aggregating agents
(negative controls). The negative controls contained gold nanoparticles, various
aggregating agents at the concentrations noted in Table 1 Row C, and 0.02 M methanol.
Experiments were also performed examining the effect of the different salts on the
spectra of synthetic cannabinoids (Figure 19 A and B). When using the sulfate, nitrate,
CaCl2, and NaCl as aggregating agents, the strength of signal intensity of the negative
control spectrum interfered with the weak spectrum of the analyte and could not be
detected using the portable Raman system. Best results were obtained using MgCl2 and
AlCl3. Based upon the spectra produced, the limits of detection (LOD) were determined
using the peaks with the highest intensity (Table 7). The salt that produced the lowest
limit of detection for all compounds examined was MgCl2. The SERS spectrum of each
compound using MgCl2 as the aggregating agent can be seen in Figure 20.
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(A)

(B)

Figure 19: A comparison of the SERS spectrum of (A) JWH-122 at 100 ng mL-1 with
various chloride salts to that of the library spectrum of JWH-122 from the portable
Raman used. The solutions examined contained gold nanoparticles, chloride salts at the
concentrations noted in Table 1 Row C and JWH-122 in 0.02 M methanol solution. (B)
JWH-030 at 100 ng mL-1 with various chloride, sulfate and nitrate salts. The solutions
examined contained gold nanoparticles, various chloride, sulfate and nitrate salts at the
concentrations noted in Table 1 Row C, and JWH-030 in 0.02 M methanol solution.
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Figure 20: The SERS spectrum of all synthetic cannabinoids examined at 100 ng mL-1 in
0.02 M methanol concentration using 0.0015 M MgCl2 as the aggregating agent.
Aggregating
Slope
Standard
R2
LOD
Agent
Deviation
(ng/mL)
JWH-018
CaCl2
0.00007
0.025
0.75
1090
MgCl2
0.0007
0.0005
0.89
20
JWH-030
MgCl2
0.0005
0.011
0.99
68
AlCl3
0.000007
0.008
0.96
3313
JWH-073
NaCl
0.00001
0.0007
0.94
221
MgCl2
0.0007
0.03
0.98
130
JWH-081
NaCl
0.000005
0.0005
0.83
328
MgCl2
0.0018
0.040
0.94
66
JWH-122
MgCl2
0.0018
0.023
0.97
38
AlCl3
0.00003
0.0058
0.98
583
JWH-147
MgCl2
0.0031
0.091
0.89
88
AlCl3
0.000003
0.0003
0.94
266
JWH-175
CaCl2
0.0003
0.028
0.83
746
MgCl2
0.0018
0.019
0.95
30
MAM-2201
MgCl2
0.0009
0.008
0.95
27
AlCl3
0.000004
0.0007
0.98
554
AM-2201
NaCl
0.000006
0.00007
0.96
334
MgCl2
0.001
0.038
0.99
113
AlCl3
0.00002
0.010
0.91
1463
Table 7: The aggregating agent used along with the calculated slope, standard deviation,
R2, and limits of detection to determine the optimal aggregating agent to use with the
synthesized gold nanoparticles to detect 9 different synthetic cannabinoids in solution.
Drug
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4.5 Conclusion
An analysis of the gold nanoparticle and aggregating agent interaction was
performed by accessing the change in absorbance, nanoparticle size, and nanoparticle
zeta potential with monovalent, divalent, and trivalent chloride, sulfate, and nitrate salts.
Results showed that divalent and trivalent cations achieve the CCC at lower
concentrations compared to monovalent cations. Data from Zetasizer measurements
indicate that the observed color changes are the result of the formation of larger
aggregates of nanoparticles with an average size that increases with added salt
concentration. There is also a corresponding reduction in charge indicating adsorption of
cations following salt addition. Our results demonstrate the strong effect of divalent and
trivalent cations in producing aggregation. The effects are independent of ionic strength
and appear to correspond to the Hoffmeister effects. When used to examine the SERS
effect on cannabinoids which are generally compounds, di and trivalent cations produce
aggregation at the lowest concentration. This can be an important advantage for SERS
measurements as these lower concentrations reduce background signal.
The optimal SERS procedure involved the use of MgCl2 as the aggregating agent
to detect nine synthetic cannabinoids with limits of detection ranging from 20–130 ng
mL-1 using a portable Raman system. Even lower detection limits may be obtained using
a benchtop system.87 This developed SERS method is simple, sensitive and should be a
useful technique for screening toxicological samples.
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5. THE INITIAL ASSESSMENT OF SERS FOR THE TOXICOLOGICAL
ANALYSIS OF SYNTHETIC CANNABINOID METABOLITES IN SPIKED URINE
SAMPLES
5.1 Abstract
As more and more synthetic cannabinoids are discovered and become scheduled,
newer compounds having similar effects on the CB1 and CB2 receptors are being
developed. In this new normal, a method needs to be developed to detect the current
synthetic cannabinoids and their metabolites as well as those to be developed in the
future. The current workhorse screening method for the detection of these compounds
and their metabolites are immunoassays.
While these immunoassays have cross-reactivity and can detect compounds with a
similar chemical structure, as newer compounds with different chemical structures are
created newer immunoassays need to be developed. This can take a long time. However,
SERS can be used to detect the current synthetic cannabinoids on the market and those in
created in the future.
Upon the development of an optimized SERS method for the detection of pure
synthetic cannabinoid parent compounds, a study was conducted the on the detection of
two synthetic cannabinoid metabolites in spiked urine samples. Each spiked urine sample
was extracted using SLE or µ-SPE followed by SERS. While the JWH-018 metabolites
could not be detected using SLE, they could be detected using µ-SPE.
5.2 Introduction
SERS In recent years there has been an emergence in the development, use, and
abuse of novel psychoactive substances (NPS). One subgroup of these substances are
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synthetic cannabinoids, which produce effects on the CB1 and/or CB2 receptors to mimic
the effects of naturally occurring cannabinoids.2,3 Initially, these compounds were studied
as legal alternative to the naturally occurring and controlled delta-9-THC. Currently,
synthetic cannabinoids are schedule I controlled substances in the United States.
Toxicologically, a variety of immunoassays12-15,18 and LC-MS12,15,19,21-23 methods
have been developed to detect the current synthetic cannabinoid compounds being used.
As newer synthetic cannabinoids are being synthesized, newer immunoassays need to be
developed to detect these compounds. Immunoassays can be a great tool in toxicology to
combat this issue due to their cross-reactivity, detecting a wide range of compounds with
a similar chemical structure. However, not all synthetic cannabinoids have the same base
chemical structure that produce the antibody antigen interaction needed to see a color
change to detect future compounds of interest. There are currently developed methods
that can be used to combat this threat, such as surface enhanced Raman spectroscopy
(SERS).
SERS uses metallic nanoparticles along with aggregating agents to be able to
detect compounds at low ng/mL concentrations. Previous work from my research group
has demonstrated the detection of various synthetic cannabinoids in oral fluids using
SERS. JWH-018 was detected in spiked oral fluid with a LOD of 0.8 ng/mL in using a µSPE method consisting of C-18 stationary phase packed within ZipTip pippettes.87
However, to date, little work has been performed on the detection of synthetic
cannabinoid metabolites in urine samples using SERS.
Another important factor in the detection of synthetic cannabinoids in biological
samples is the extraction method used. One such extraction method is supported liquid
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extraction, (SLE). In SLE, the aqueous media is supported by diatomaceous earth, a polar
support material. In the extraction process, non-polar drugs and metabolites move to the
surface of the aqueous phase where they can be captured by a nonpolar organic solvent.99
This method is fast and does not require any column pretreatment like SPE. In total, from
extraction to analysis can be done in less than 40 minutes per sample, including sample
prep, extraction, and analysis.45 Previously, our research group developed an optimal
SERS method for the detection of nine synthetic cannabinoid parent compounds.100 Gold
nanoparticles and MgCl2 along with SLE have been used to detect 11 different
benzodiazepines spiked in urine samples with limits of detection ranging from 0.5 to 120
ng/mL.45
Another extraction method examined utilized µ-SPE. The method used a 10 µL
ZipTip pipette tip with 0.6 µL of a C18 reverse phase particles. The procedure is
convenient and can be completed in less than 36 minutes of total analysis time.87 It is
capable of detecting JWH-018 in spiked oral fluid samples with a LOD of 0.8 ng/mL.87
The goal of this study was to see if SLE or a ZipTip extraction method could be
combined with SERS could be used to detect synthetic cannabinoid metabolites in spiked
urine samples. Synthetic cannabinoid metabolites were examined in this part of the study
since the parent compounds are not commonly found in urine samples. This study was
split into two parts. First, the optimal SERS method developed in the previous chapter for
synthetic cannabinoid parent compounds was used to detect JWH-018 N-pentanoic acid
and JWH-018 N-(5-hydroxypentyl) metabolites (Figure 18) diluted in 10% methanol.
This Raman spectrum was set as a baseline to determine if the synthetic cannabinoid
could be extracted using SLE or ZipTip. The second part of this study focused on the two

76

extraction methods. In SLE, a few sample pretreatments and one post treatment method
were compared in order to optimize the detection of two JWH-018 metabolites in spiked
urine samples. The ZipTip extraction method was similar to what was previously
developed for cannabinoids in saliva.87 After a variety of samples examined, JWH-018
N-pentanoic acid and JWH-018 N-(5-hydroxypentyl) metabolites could not be detected in
spiked urine samples via SLE and SERS, but could be detected using the ZipTip
extraction method.

Figure 21: The chemical structures of JWH-018 N-pentanoic acid metabolite (left) and
JWH-018 N-(5-hydroxypentyl) metabolite (right) examined in this study.
5.3 Experimental
5.3.1 Materials used
The gold nanoparticle colloids were prepared following the same procedure seen
in chapters 3 and 4. 100 mL gold nanoparticle solutions were prepared reducing
tetrachloroauric (iii) acid trihydrate (Acros Organics, LOT#A0354619) with 4 mL of a
1% by weight solution of sodium citrate dihydrate (Fisher Scientific, LOT #091236) at
pH 5. A stock solution of 0.15M MgCl2 (Fisher Scientific) was used as the aggregating
agent in this study.
Synthetic cannabinoid standards of JWH 018 N-(5-hydroxypentyl) metabolite
(LOT #0448993-60) and JWH-018 N-pentanoic acid metabolite (LOT #0498078-28)
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were obtained from Cayman Chemical. Both standards were used to create stock standard
solutions at concentrations ranging from 25–20000 ng/mL in a 10% methanol solution.
5.3.2 SLE+ extraction
The SLE method examined is similar to the methods examined by Doctor et al.45
Spiked urine samples of JWH 018 N-(5-hydroxypentyl) metabolite and JWH-018 Npentanoic acid metabolite in 10% methanol were analyzed. In this process, 500 µL of the
synthetic cannabinoid metabolite and 500 µL of urine were added to a clear 4 mL glass
vial (Fisher Scientific) and vortexed. Then, either 1 mL of DI water, 1 mL of 50 mM
NH4OAc buﬀer solution (adjusted to pH 2 with 1% formic acid), or 1 mL of 50 mM
NH4OAc buﬀer solution (adjusted to pH 4 with 1% formic acid) were added to the 4 mL
glass vial and vortexed (total solution volume of 2 mL) and applied to the Biotage Isolute
supported liquid extraction (SLE)+ 2 mL column under vacuum and let to sit for five
minutes. Next, a wash of 2.5 mL dichloromethane (Fisher Scientific Lot #138217) was
applied to the SLE+ column and let sit for five minutes. Then, another wash of 2.5 mL
dichloromethane was applied to the SLE+ column and let sit for five minutes and eluted
under vacuum for 10 seconds. Finally, the eluted dichloromethane was dried down under
nitrogen gas, and reconstituted with 500 µL of 10% methanol.
Some addition modifications were examined to see if the synthetic cannabinoid
metabolites could be extracted. Some samples were treated with 100 µL of acidified
methanol prior to being dried down and reconstituted with 10% methanol. In addition,
instead of two washes of 2.5 mL dichloromethane applied to the SLE column, one wash
of 2mL dichloromethane was examined.
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5.3.3 Micro-SPE extraction
The µ-SPE extraction method using ZipTip pipette tips is similar to the method
developed by Deriu et al.87 For this method, 150 µL of spiked urine samples containing
JWH 018 N-(5-hydroxypentyl) metabolite and JWH-018 N-pentanoic acid metabolite in
pure methanol were added to 250 µL of urine (400 µL total volume, with 37.5% v/v
methanol) and centrifuged for 10 minutes at speed of 12.4 revolutions per minute. Then,
49.5 µL of the spiked urine sample was removed and placed in a 2 mL glass vial (Fisher
Scientific) with the addition of 0.5 µL of DI water adjusted to pH 2.5 with formic acid
(Acros Organics, lot # A0022334000) and vortexed.
After ample preparation, the ZipTip 10 μL pipet tips (Millipore, lot #
R7EA90580), fitted with a 0.6 μL reversed phase C18 chromatographic bed with no dead
volume was conditioned with two washes of 10µL of 100% acetonitrile (UHPLC/UV
grade, Fisher Chemical, lot #181464) followed by two washes of 10 µL of DI water
acidified to pH 2.5 via addition of formic acid at a final concentration of 1% v/v. Then,
the ZipTip was washed ten times with 10 µL of the urine sample with formic acid.
Finally, the ZipTip was washed with 4 µL of the methanol and eluted into a 2 mL glass
vial.
5.3.4 SERS analysis of metabolites
The SLE treated samples followed the procedure previously explained in chapters
3 and 4 of this work: 980 μL of the gold nanoparticle solution and 10 μL of 0.15 MgCl2
solution were placed in a clear 2 mL glass vial (Fisher Scientific) vortexed for 30 seconds
followed by the addition of 10 μL of the pure metabolites or the extracted metabolites and
vortexed for 30 seconds. The µ-SPE method followed a similar procedure to Deriu et al.87
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After 4 µL of methanol was eluted from the ZipTip, then 245 µL of gold nanoparticle
solution was added and vortexed for 30 seconds followed by 2.5 μL of 0.15 MgCl2. The
concentration of spiked urine samples ranged from 25-20000 ng/mL. Each sample was
run in triplicate. The final concentration of each component in the for the pure and SLE
samples was as follows: 0.05 mM HAuCl4, 0.0015 M MgCl2, and between 2.5–2000
ng/mL of pure or extracted metabolites. The final concentration of each component in the
µ-SPE samples was as follows: 0.05 mM HAuCl4, 0.0015 M MgCl2, and between 9.4–
7500 ng/mL of extracted metabolites.
5.3.5 Instrumentation
The extracted SERS solutions were transferred to a quartz Suprasil® cuvette
(Hellma Analytics) and analyzed via the Thermo Scientific FirstDefenderRM (portable)
with a 785 nm laser at high power (250 mW) with a resolution of 7 to 10.5 cm -1
(FWHM).
5.4 Results and discussion
5.4.1 SERS analysis of metabolite standards
In this study, metabolites of JWH-018 were examined. The goal of this study was
to develop a fast and easy extraction method that could be used to detect synthetic
cannabinoids in urine. Initially, the synthetic cannabinoid standards were analyzed via the
optimized SERS method developed in chapter 4. The SERS spectrum of each
cannabinoid metabolite ranging between 2.5 – 20000 ng/mL can be seen in Figure 22.
The results show that these compounds can be detected at concentrations as low as 2.510ng/mL.
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Figure 22: The SERS spectrum of JWH-018 N-(5-hydroxypentyl) metabolite ranging
from 2.5-2000 ng/mL (top) and The SERS spectrum of JWH-018 N-pentanoic acid
metabolite ranging from 2.5-2000 ng/mL (bottom).
In addition, the Raman intensity at a specific peak in the Raman spectra for each
compound was plotted versus the concentration (Figure 23). The results demonstrate the
expected Langmuir adsorption behavior and illustrate the capability of the method to
detect physiological concentrations of the metabolites. A comparison of the SERS
spectrum of the JWH-018 metabolites to the parent compound can be seen in Figure 24.
The SERS spectrum of the pure drug and the JWH metabolites are discussed in detail in
chapter 6.
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Figure 23: A plot of Raman intensity of a specific peak for each JWH-018 metabolite
(pure drug) versus the concentration.

Figure 24: Comparison of the SERS spectrum of JWH-018 (100 ng/mL), JWH-018 (N-5hydroxypentyl) metabolite (100 ng/mL), and JWH-018 N-pentanoic acid metabolite (500
ng/mL) in 10% methanol.
5.4.2 SLE+ extraction of synthetic cannabinoids
After the metabolite standards were analyzed via the optimized SERS method in
chapter 4, 500µL of each metabolite concentration was spiked to 500 µL of urine and
extracted. Prior to adding the spiked urine sample to the SLE column samples were
pretreated with 1 mL of DI water, 1 mL of 50 mM NH4OAc buﬀer solution (adjusted to
pH 2 with 1% formic acid), or 1 mL of 50 mM NH4OAc buﬀer solution (adjusted to pH 4
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with 1% formic acid). The resultant spectra could not be distinguished from the negative
control (Figure 25). Based upon the results, it was clear that the synthetic cannabinoid
metabolites were lost in the extraction process, and an alternative extraction method was
necessary.

Figure 25: Comparison of the SERS spectrum of JWH-018 N-pentanoic acid metabolite
(500 ng/mL) prior to extraction and JWH-018 N-pentanoic acid metabolite spiked urine
sample (1000 ng/mL) pretreated with 1 mL of 50 mM NH4OAc buﬀer solution (adjusted
to pH 4 with 1% formic acid).
5.4.3 Micro-SPE of synthetic cannabinoids
To improve the extraction process, a µ-SPE method was developed using 0.6 μL
of a reversed phase C18 chromatographic bed packed within a 10 µL pipette tip. MicroSPE is completed in five steps: wetting, equilibration, binding, washing and elution. The
entire process from sample to measurement takes under 36 minutes.87 The SERS
spectrum of each compound after the µ-SPE extraction is shown in Figure 26. The results
show a clear distinction between the parent drug and the metabolites. In initial
experiments examining the potential of µ-SPE for sensitivity, the JWH-018 N-(5-
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hydroxypentyl) metabolite was detected at concentrations as low as 250 ng/mL and the
JWH-018 N-pentanoic acid metabolite as low as 375 ng/mL. These results demonstrate
the potential of zip tip based solid phase extraction. Further experiments are necessary to
optimize recovery and improve detection.

Figure 26: A comparison of the SERS spectrum of the JWH-018 N-(5-hydroxypentyl)
metabolite as the pure drug (100 ng/mL) and after µ-SPE extraction (375 ng/mL) as well
as JWH-018 N-pentanoic acid metabolite as the pure drug (250 ng/mL) and after µ-SPE
(375 ng/mL).
5.5 Conclusion
The use of SLE and µ-SPE with SERS was examined as a possible method to
detect two JWH-018 metabolites in spiked urine samples. Prior to an extraction and
spiking of urine samples, the metabolites were analyzed via the optimized SERS method
developed in chapter 4, at concentrations as low as 2.5 ng/mL. Initial analysis using SLE
to extract the metabolites from the spiked urine samples did not produce a SERS
spectrum different from the negative control. This could be due to matrix interferences
in the urine samples or loss of sample during extraction. Initial results using µ-SPE
demonstrated the detection of the drug metabolites at concentrations as low as 250ng/mL.
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These results indicate that with further optimization, µ-SPE should provide a useful
method for the extraction JWH-018 metabolites in urine samples.
6.VIBRATIONAL SPECTRAL ANALYSIS OF SYNTHETIC CANNABINOIDS
6.1 Introduction
Spectroscopy measures vibrational frequencies produced from inter or intra
molecular bond vibrations. The two types main types of molecular bond vibrations
between atoms are stretching vibrations (symmetric and antisymmetric) and deformation
vibrations (bending, wagging, twisting, and rocking).26 The two spectroscopic techniques
that measure these vibrations are IR and Raman spectroscopy. Infrared spectroscopy is
related to the change in the dipole moment of a molecule, whereas the Raman reflects the
change in polarizability. Molecular bonds of a molecule can be either IR active, Raman
active, or both.
A few articles have been published on the structural interpretation on the Raman
spectrum of some synthetic cannabinoids. Deriu et al. used density functional theory
(DFT) calculations to determine the vibrational assignments of JWH-018 in solid state
and in oral fluid via SERS.87 Alkaseem et al. used DFT calculations to determine the
vibrational assignments of 5F-PB-22 standard in solid state and in solution via SERS.
The differences in the powder, SERS, and DFT calculated Raman spectrum were
discussed 50 In addition, a similar comparison of AMB-FUBINACA was conducted by
Islam et al. using DFT calculations to assign the major peaks in each Raman spectrum.49
The above articles were used to identify the various peaks in the SERS spectrum
of the synthetic cannabinoid parent and metabolite compounds examined in this study.
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The study by Deriu et al was used to assign the peaks of JWH-018. Since the additional
parent and metabolite compounds were similar in structure, the peak assignments of the
additional compounds were based on the initial assignments of JWH-018. For the
fluorinated synthetic cannabinoid compounds examined, the carbon fluorine single bond
assignment was based on the work of Alkaseem et al. In this spectral interpretation, the
strength of the bands as well as the stretching and deformation vibrations are noted. The
band strength is noted as follows: strong (s), moderate (m), weak (w), and very weak
(vw).
6.2 Analysis of Peaks for All synthetic cannabinoids and Major Subgroups
The structure of the synthetic cannabinoids examined in this study are
aminoalkylindoles (Figure 1) that can be broken down into 4 major groups: core group,
linker, linked group and tail.87 (Figure 27). The core group is the indole. The linker is a
ketone. The linked group is naphthalene. The tail is an alkane chain. The SERS spectrum
with the chemical structure as well as peak identification of JWH-018 can be seen in
Figure 28 and Table 8.

Figure 27: The identification of the four major groups of aminoalkylindoles (JWH-073):
linked group (red), linker (green), core group (blue), and tail (purple). 87
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Wavenumber
1610 w
1573 w
1530 w
1509 w
1463 w
1393 w
1370 s
1338 w
1272 w
1251 w
1207 vw
1183 vw
1160 vw
1134 m
1096 vw
1074 w
1017 vw
1000 vw
960 w
931 w
886 vw
867 vw
775 m
672 w
640 w
619 vw
589 w
541 w
510 w
421 w

Assignment
C=C stretching indole rings
C=C stretching naphthalene ring
(C=C) CCN stretching; (CH) NCH2 in plane deformation
(C=C) CCN stretching; (CH) NCH2 in plane deformation
CH2 scissoring; CH3 scissoring within indole ring; CH scissoring within
naphthalene ring
CH in plane rocking within naphthalene ring
C=C stretching in naphthalene ring
C=C stretching within indole ring; CH in plane scissoring within indole or
naphthalene ring
CH2 out of plane twisting; CH in plane scissoring in indole and naphthalene ring
HCH out of plane wagging form tail; CH in plane scissoring within the indole or
naphthalene ring
CH in plane scissoring in naphthalene ring; CH2 out of plane twisting, CH3 out of
plane twisting in the tail
CH in plane scissoring in indole ring; CH in plane rocking of the indole and
naphthalene ring
HCCH in plane stretching on the indole and naphthalene ring
(CH) NCH in plane scissoring
HCCH naphthalene ring in plane scissoring; CH2 out of plane twisting; CH3 out of
plane wagging on the tail
HCCH naphthalene ring in plane scissoring
Indole ring breathing; CC stretching within the tail
Indole ring breathing; CC stretching within the tail
CH Naphthalene ring or of plane wagging
CH out of plane wagging within the naphthalene ring
CCH3 stretching; in plane deformation within the idole ring or naphthalene ring
CCH3 stretching; in plane deformation within the idole ring or naphthalene ring
Indole ring breathing; CH out of plane wagging within naphthalene ring
In plane deformation within naphthalene or indole ring
In plane deformation within naphthalene ring
In plane deformation within naphthalene ring
In plane deformation within naphthalene ring and out of plane deformation indole
ring
In plane deformation within naphthalene or indole ring
In plane deformation within naphthalene ring
CH out of plane wagging in naphthalene ring; Indole ring in plane deformation

Table 8: Vibrational assignment of peaks in the SERS spectrum of JWH-018.
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Figure 28: Chemical structure and SERS spectrum of JWH-018
All the SERS spectra discussed in this chapter were obtained using the Thermo
Scientific First Defender RM (portable) with a 785 nm laser at high power (250 mW)
with a resolution of 7 to 10.5 cm-1 (FWHM). Upon initial visualization of each synthetic
cannabinoid examined, there are differences in the peak shape. However, due to the
resolution of the instrument used, it cannot be stated that each compound produced a
unique Raman spectrum that can be identified from each other. Instead, this research has
shown that compounds of a similar chemical structure will have similarities in the Raman
spectrum. Having this knowledge is important when attempting to do structural
elucidation of an unknown compound using this method.
There are many peaks present in the SERS spectrum that could be due to more
than one type of molecular bond vibration within the chemical structure of the synthetic
cannabinoids examined in this study. However, there is a portion of the chemical
structure missing in the SERS spectrum of all the parent compounds, except JWH-175,
and metabolites examined. There is no peak around the 1650 cm-1 region of the SERS
spectrum, which would be related to the ketone portion of the chemical structure. This
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peak is the linker portion of the molecule. In addition, there are portions of the
metabolites chemical structure missing from the SERS Spectrum. Each metabolite is
missing a broad peak from OH bond stretching, seen between 3000 - 3600 cm-1 and the
pentanoic acid metabolite is missing a peak from the C=O stretching of the carboxylic
acid portion of the chemical structure around 1750 cm-1. These peak identifications are
based upon the studies conducted by Munchi et al. on identification of GHB and GBL
and Sun et al. on the OH stretching vibration of ice. 101,102 One reason for not seeing a
broad 0H stretching peak between 3000 - 3600 cm-1 is the limitation of the scan range of
the portable Raman system, which reached only as far as 2900 cm-1. A larger scan range
could increase the chance of seeing the SERS peak. However, another limitation to the
SERS analysis is the rotation of the molecule present in the nanoparticle solution and the
angle at which the incident light (laser) hits the sample to produce the SERS
enhancement. Therefore, a portion of the chemical structure could be missing from the
SERS spectrum. This could explain the variations in the SERS spectrum between the
pure drug of the metabolites and after µ-SPE of spiked urine samples. For a detailed
analysis of the additional compounds examined see Chapter 6.3.
6.3 Spectral Analysis of additional synthetic cannabinoids examined
The SERS spectrum of each synthetic cannabinoid parent and metabolite
examined along with the chemical structure of each compound can be seen in the figures
below. The identification of each peak in the corresponding Raman spectrum can be seen
in the tables below.
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6.3.1 JWH-030

Figure 29: Chemical structure and SERS spectrum of JWH-030.
Wavenumber
1573 m
1526 m
1440 m
1408 w
1370 s
1289 w
1235 m
1195 w
1160 w
1124 vw
1113 vw
1074 w
1050 w
1019 w
1003 vw
981 vw
904 w
795 vw
769 vw
752 vw
674 w
608 w
584 w
559 w
504 w
468 vw
408 w

Assignment
C=C stretching naphthalene ring
(C=C)CCN stretching; (CH) NCH2 out of plane deformation
CH out of plane rocking in the naphthalene ring
CH in plane rocking in the naphthalene ring
C=C stretching in naphthalene ring
CH2 out of plane twisting; CH in plane scissoring for indole and naphthalene ring
HCH out of plane wagging form tail; CH in plane scissoring within the idole or naphthalene ring
CH in plane scissoring on pyrrole ring; CH in plane rocking on pyrrole and naphthalene ring
HCCCH in plane scissoring of naphthalene ring
(CH)NCH in plane scissoring
CH2 out of plane wagging, CH3 out of plane wagging on the tail; CH in plane scissoring on the
naphthalene ring
HCCCH in plane scissoring of naphthalene ring
C-C tail stretching
Pyrrole ring breathing; C-C tail stretching
Pyrrole ring breathing; C-C tail stretching
CH naphthalene ring out of plane wagging
CCH3 stretching; in plane deformation within the idole ring or naphthalene ring
CH2 in plane rocking; CH3 in plane rocking; (CH)NCH out of plane wagging
Indole ring breathing; CH out of plane wagging within naphthalene ring
CH2 in plane rocking; CH3 in plane rocking
In plane deformation within naphthalene
In plane deformation within naphthalene ring
In plane deformation within naphthalene ring and out of plane deformation indole ring
Out of plane deformation of the indole ring
In plane deformation within naphthalene ring
Out of plane deformation of the naphthalene ring
CH out of plane wagging in naphthalene ring; Indole ring in plane deformation

Table 9: Vibrational assignment of peaks in the SERS spectrum of JWH-030.
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6.3.2 JWH-073

Figure 30: Chemical structure and SERS spectrum of JWH-073.
Wavenumber
1608 w
1573 w
1529 w
1512 w
1466 w
1391 vw
1370 s
1338 w
1249 w
1213 w
1158 w
1132 vw
1074 vw
1001 w
923 vw
886 w
801 vw
775 m
671 m
642 w
621 vw
586 w
541 vw
419 m

Assignment
C=C stretching idole rings
C=C stretching naphthalene ring
(C=C) CCN stretching; (CH) NCH2 in plane deformation
(C=C) CCN stretching; (CH) NCH2 in plane deformation
CH2 scissoring; CH3 scissoring within idole ring; CH scissoring within naphthalene
ring
CH in plane rocking within naphthalene ring
C=C stretching in naphthalene ring
C=C stretching within indole ring; CH in plane scissoring within indole or
naphthalene ring
HCH out of plane wagging form tail; CH in plane scissoring within the idole or
naphthalene ring
CH in plane scissoring in naphthalene ring; CH2 out of plane twisting, CH3 out of
plane twisting in the tail
HCCH in plane stretching on the indole and naphthalene ring
HCCH in plane scissoring within the indole ring; (CH) NCH in plane scissoring
HCCCH in plane scissoring of naphthalene ring
Indole ring breathing; CC stretching within the tail
CH out of plane wagging within the naphthalene ring
CCH3 stretching; in plane deformation within the idole ring or naphthalene ring
CH2 in plane rocking; CH3 in plane rocking; (CH)NCH out of plane wagging
Indole ring breathing; CH out of plane wagging within naphthalene ring
In plane deformation within naphthalene or indole ring
In plane deformation within naphthalene ring
In plane deformation within naphthalene ring
In plane deformation within naphthalene ring and out of plane deformation indole
ring
In plane deformation within naphthalene or indole ring
CH out of plane wagging in naphthalene ring; Indole ring in plane deformation

Table 10: Vibrational assignment of peaks in the SERS spectrum of JWH-073.
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6.3.3 JWH-081

Figure 31: Chemical structure and SERS spectrum of JWH-081.
Wavenumber
1578 m
1556 w
1508 m
1461 w
1391 vw
1372 s
1335 vw
1284 vw
1251 m
1206 w
1131 m
1095 m
971 vw
952 w
929 w
867 w
835 vw
775 m
715 m
663 w
623 w
563 vw
539 vw
430 m

Assignment
C=C stretching naphthalene ring
C=C stretching indole and naphthalene ring
(C=C) CCN stretching; (CH) NCH2 in plane deformation
CH2 scissoring; CH3 scissoring within idole ring; CH scissoring within naphthalene
ring
CH in plane rocking within naphthalene ring
C=C stretching in naphthalene ring
C=C stretching within indole ring; CH in plane scissoring within indole or
naphthalene ring
CH2 out of plane twisting; CH in plane scissoring for indole and naphthalene ring
HCH out of plane wagging form tail; CH in plane scissoring within the idole or
naphthalene ring
CH in plane scissoring in naphthalene ring; CH2 out of plane twisting, CH3 out of
plane twisting in the tail
HCCH in plane scissoring within the indole ring; (CH) NCH in plane scissoring
HCCH in plane scissoring within naphthalene ring; CH2 out of plane twisting, CH3
out of plane wagging on the tail
CH out of plane wagging in naphthalene ring
CH out of plane wagging within the naphthalene ring
CH out of plane wagging within the naphthalene ring
CCH3 stretching; in plane deformation within the idole ring or naphthalene ring
CH2 in plane rocking; CH3 in plane rocking; (CH)NCH out of plane wagging
Indole ring breathing; CH out of plane wagging within naphthalene ring
CH out of plane wagging in indole and naphthalene ring
In plane deformation within naphthalene
Indole ring in plane deformation
Indole ring out of plane deformation
In plane deformation within naphthalene or indole ring
CH out of plane wagging in naphthalene ring; Indole ring in plane deformation

Table 11: Vibrational assignment of peaks in the SERS spectrum of JWH-081.

92

6.3.4 JWH-122

Figure 32: Chemical structure and SERS spectrum of JWH-122.
Wavenumber
1610 vw
1582 m
1530 m
1509 w
1465 m
1391 w
1363 s
1274 vw
1253 vw
1207 vw
1183 vw
1149 vw
1127 m
1065 vw
1004 w
954 w
927 w
869 w
825 vw
773 m
735 vw
699 m
665 w
576 vw
528 w
435 w

Assignment
C=C stretching idole rings
C=C stretching naphthalene ring
(C=C) CCN stretching; (CH) NCH2 in plane deformation
(C=C) CCN stretching; (CH) NCH2 in plane deformation
CH2 scissoring; CH3 scissoring within idole ring; CH scissoring in naphthalene ring
CH in plane rocking within naphthalene ring
C=C stretching in naphthalene ring
CH2 out of plane twisting; CH in plane scissoring for indole and naphthalene ring
HCH out of plane wagging form tail; CH in plane scissoring within the idole or
naphthalene ring
CH in plane scissoring in naphthalene ring; CH2 out of plane twisting, CH3 out of
plane twisting in the tail
CH in plane scissoring on indole ring; CH in plane rocking on indole and naphthalene
ring
HCCH in plane stretching on the indole and naphthalene ring
HCCH in plane scissoring within the indole ring; (CH) NCH in plane scissoring
HCCCH in plane scissoring of naphthalene ring
Indole ring breathing; CC stretching within the tail
CH out of plane wagging within the naphthalene ring
CH out of plane wagging within the naphthalene ring
CCH3 stretching; in plane deformation within the idole ring or naphthalene ring
CH2 in plane rocking; CH3 in plane rocking; (CH)NCH out of plane wagging
Indole ring breathing; CH out of plane wagging within naphthalene ring
CH indole and naphthalene ring out of plane wagging
CH indole and naphthalene ring out of plane wagging
In plane deformation within naphthalene
In plane deformation within naphthalene ring and out of plane deformation indole
ring
In plane deformation within naphthalene or indole ring
CH out of plane wagging in naphthalene ring; Indole ring in plane deformation

Table 12: Vibrational assignment of peaks in the SERS spectrum of JWH-122.
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6.3.5 JWH-147

Figure 33: Chemical structure and SERS spectrum of JWH-147.
Wavenumber
1604 w
1575 w
1530 m
1432 m
1370 m
1270 vw
1244 vw
1179 vw
1107 w
1071 w
996 vw
988 vw
890 vw
874 w
791 vw
779 w
746 w
672 m
631 vw
610 vw
591 vw
524 vw
508 vw
407 vw

Assignment
C=C stretching idole rings
C=C stretching naphthalene ring
(C=C)CCN stretching; (CH) NCH2 out of plane deformation
CH out of plane rocking in the naphthalene ring
C=C stretching in naphthalene ring
CH2 out of plane twisting; CH in plane scissoring for indole and naphthalene ring
HCH out of plane wagging form tail; CH in plane scissoring within the idole or
naphthalene ring
HCCCH in plane scissoring of naphthalene ring
(HCCH) in plane scissoring of naphthalene ring; CH2 out of plane twisting, CH3 out of
plane wagging from the tail
HCCCH in plane scissoring of naphthalene ring
C-C tail stretching; indole and naphthalene ring stretching
CH naphthalene ring out of plane wagging
CCH3 stretching; indole and naphthalene ring stretching
CCH3 stretching; in plane deformation within the idole ring or naphthalene ring
CH2 in plane rocking; CH3 in plane rocking; (CH)NCH out of plane wagging
Indole ring breathing; CH out of plane wagging within naphthalene ring
CH2 in plane rocking; CH3 in plane rocking
In plane deformation within naphthalene
In plane deformation within naphthalene or indole ring
In plane deformation within naphthalene ring
In plane deformation within naphthalene ring and out of plane deformation indole ring
In plane deformation within naphthalene or indole ring
In plane deformation within naphthalene ring
CH out of plane wagging in naphthalene ring; Indole ring in plane deformation

Table 13: Vibrational assignment of peaks in the SERS spectrum of JWH-147.
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6.3.6 AM-2201

Figure 34:Chemical structure and SERS spectrum of AM-2201.
Wavenumber
1608 vw
1575 m
1530 m
1511 m
1466 m
1393 w
1370 s
1338 w
1246 m
1156 vw
1131 m
1095 vw
1074 w
1004 w
960 w
929 m
886 w
865 w
801 w
777 m
674 m
642 w
619 vw
587 vw
541 m
508 m
417 m

Assignment
C=C stretching idole rings
C=C stretching naphthalene ring
(C=C)CCN stretching; (CH) NCH2 out of plane deformation
(C=C) CCN stretching; (CH) NCH2 in plane deformation
CH2 scissoring; CH3 scissoring within idole ring; CH scissoring in naphthalene ring
CH in plane rocking within naphthalene ring
C=C stretching in naphthalene ring
C=C stretching within indole ring; CH in plane scissoring in indole or naphthalene ring
HCH out of plane wagging form tail; CH in plane scissoring within the idole or naphthalene
ring
HCCH in plane scissoring within the indole or naphthalene ring
HCCH in plane scissoring within the indole ring; (CH) NCH in plane scissoring
(HCCH) in plane scissoring of naphthalene ring; CH2 out of plane twisting, CH3 out of plane
wagging from the tail
HCCCH in plane scissoring of naphthalene ring
Indole ring breathing; CC stretching within the tail
CH out of plane wagging within the naphthalene ring
CH out of plane wagging within the naphthalene ring
CCH3 stretching; in plane deformation within indole or naphthalene ring
CCH3 stretching; in plane deformation within the idole ring or naphthalene ring; CF stretch
CH2 in plane rocking; CH3 in plane rocking; (CH)NCH out of plane wagging
Indole ring breathing; CH out of plane wagging within naphthalene ring
In plane deformation within naphthalene
In plane deformation within naphthalene or indole ring
In plane deformation within naphthalene ring
In plane deformation within naphthalene ring and out of plane deformation indole ring

In plane deformation within naphthalene or indole ring
In plane deformation within naphthalene ring
CH out of plane wagging in naphthalene ring; Indole ring in plane deformation

Table 14: Vibrational assignment of peaks in the SERS spectrum of AM-2201.
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6.3.7 MAM-2201

Figure 35: Chemical structure and SERS spectrum of MAM-2201.
Wavenumber

Assignment

1611 vw
1579 m
1529 s
1463 m
1391vw
1361 vs
1242 m

C=C stretching idole rings
C=C stretching naphthalene ring
(C=C)CCN stretching; (CH) NCH2 out of plane deformation
CH2 scissoring; CH3 scissoring within idole ring; CH scissoring within naphthalene ring
CH in plane rocking within naphthalene ring
C=C stretching within naphthalene ring
HCH out of plane wagging form tail; CH in plane scissoring within the idole or naphthalene
ring
HCCH in plane scissoring within the indole or naphthalene ring
HCCH in plane scissoring within the indole ring; (CH) NCH in plane scissoring
Indole ring breathing; CC stretching within the tail
CH out of plane wagging within the naphthalene ring
CH out of plane wagging within the naphthalene ring
CCH3 stretching; in plane deformation within the idole ring or naphthalene ring; CF stretch
CH2 in plane rocking; CH3 in plane rocking; (CH)NCH out of plane wagging
Indole ring breathing; CH out of plane wagging within naphthalene ring
In plane deformation within naphthalene ring
In plane deformation within naphthalene ring
In plane deformation within naphthalene or indole ring
CH out of plane wagging in naphthalene ring; Indole ring in plane deformation

1150 w
1123 m
1003 m
954 w
925 w
867 w
821 vw
772 m
699 m
663 w
526 w
432 m

Table 15: Vibrational assignment of peaks in the SERS spectrum of MAM-2201.
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6.3.8 JWH-175

Figure 36: Chemical structure and SERS spectrum of JWH-175.
Wavenumber
1610 vw
1578 m
1511 m
1468 vw
1395 w
1371 s
1338 w
1273 vw
1251 w
1206 vw
1165 vw
1133 m
1102 vw
1074 w
1017 w
1003 vw
954 vw
925 w
886 vw
861 w
777 m
674 m
642 vw
621 vw
587 w
541 w
508 w
421 w

Assignment
C=C stretching idole rings
C=C stretching naphthalene ring
(C=C) CCN stretching; (CH) NCH2 in plane deformation
CH2 scissoring; CH3 scissoring within idole ring; CH scissoring within naphthalene ring
CH in plane rocking within naphthalene ring
C=C stretching in naphthalene ring
C=C stretching within indole ring; CH in plane scissoring within indole or naphthalene ring
CH2 out of plane twisting; CH in plane scissoring for indole and naphthalene ring
HCH out of plane wagging form tail; CH in plane scissoring within the idole or naphthalene
ring
CH in plane scissoring in naphthalene ring; CH2 out of plane twisting, CH3 out of plane
twisting in the tail
HCCH in plane scissoring within the indole or naphthalene ring
HCCH in plane scissoring within the indole ring; (CH) NCH in plane scissoring
(HCCH) in plane scissoring of naphthalene ring; CH2 out of plane twisting, CH3 out of plane
wagging from the tail
HCCCH in plane scissoring of naphthalene ring
Indole ring breathing; C-C stretching in the tail
Indole ring breathing; CC stretching within the tail
CH out of plane wagging within the naphthalene ring
CH out of plane wagging within the naphthalene ring
CCH3 stretching; in plane deformation within indole or naphthalene ring
CCH3 stretching; in plane deformation within the idole ring or naphthalene ring
Indole ring breathing; CH out of plane wagging within naphthalene ring
In plane deformation within naphthalene
In plane deformation within naphthalene or indole ring
In plane deformation within naphthalene ring
In plane deformation within naphthalene ring and out of plane deformation indole ring
In plane deformation within naphthalene or indole ring
In plane deformation within naphthalene ring
CH out of plane wagging in naphthalene ring; Indole ring in plane deformation

Table 16: Vibrational assignment of peaks in the SERS spectrum of JWH-175.
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6.3.9 JWH-018 N-pentanoic acid metabolite

Figure 37: Chemical structure and SERS spectrum of JWH-018 N-pentanoic acid.
Wavenumber
1604 vw
1559 m
1530 s
1441vw
1370 m
1338 m
1248 w
1156 vw
1113 vw
1080 vw
1013 w
996 vw
902 w
799 vw
773 w
668 vw
640 vw
541 vw
491 vw

Assignment
C=C stretching idole rings
C=C stretching naphthalene ring
(C=C) CCN stretching; (CH) NCH2 in plane deformation
CH2 scissoring; CH3 scissoring within idole ring; CH scissoring within naphthalene ring
C=C stretching in naphthalene ring
C=C stretching within indole ring; CH in plane scissoring within indole or naphthalene ring
HCH out of plane wagging form tail; CH in plane scissoring within the idole or naphthalene
ring
HCCH in plane scissoring within the indole or naphthalene ring
HCCH in plane scissoring within the indole ring; (CH) NCH in plane scissoring
HCCCH in plane scissoring of naphthalene ring
Indole ring breathing; C-C stretching in the tail
CH out of plane wagging within the naphthalene ring
CH out of plane wagging within the naphthalene ring
Indole ring breathing; CH out of plane wagging within naphthalene ring
Indole ring breathing; CH out of plane wagging within naphthalene ring
In plane deformation within naphthalene
In plane deformation within naphthalene or indole ring
In plane deformation within naphthalene or indole ring
CH out of plane wagging in naphthalene ring; Indole ring in plane deformation

Table 17: Vibrational assignment of peaks in the SERS spectrum of JWH-018 Npentanoic acid.
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6.3.10 JWH-018 N-(5-hydroxypentyl) metabolite

Figure 38: Chemical structure and SERS spectrum of JWH-018 N-(5-hydroxypentyl)
metabolite.
Wavenumber
1634 vw
1526 m
1461 vw
1370 s
1338 m
1274 vw
1253 vw
1154 vw
1080 vw
1015 m
1003 vw
927 w
884 vw
801 w
771 m
670 m
587 w
541 w
506 w
426 w

Assignment
C=C stretching idole rings
C=C stretching naphthalene ring
CH2 scissoring; CH3 scissoring within idole ring; CH scissoring within naphthalene ring
C=C stretching in naphthalene ring
C=C stretching within indole ring; CH in plane scissoring within indole or naphthalene ring
CH2 out of plane twisting; CH in plane scissoring for indole and naphthalene ring
HCH out of plane wagging form tail; CH in plane scissoring within the idole or naphthalene
ring
HCCH in plane scissoring within the indole or naphthalene ring
HCCCH in plane scissoring of naphthalene ring
Indole ring breathing; C-C stretching in the tail
Indole ring breathing; CC stretching within the tail
CH out of plane wagging within the naphthalene ring
CCH3 stretching; in plane deformation within indole or naphthalene ring
CCH3 stretching; in plane deformation within the idole ring or naphthalene ring
Indole ring breathing; CH out of plane wagging within naphthalene ring
In plane deformation within naphthalene
In plane deformation within naphthalene ring and out of plane deformation indole ring
In plane deformation within naphthalene or indole ring
In plane deformation within naphthalene ring
CH out of plane wagging in naphthalene ring; Indole ring in plane deformation

Table 18: Vibrational assignment of peaks in the SERS spectrum of JWH-018 N-(5hydroxypentyl) metabolite.
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Hey
6.3.11
JWH-018 N-pentanoic acid metabolite pure drug and extraction comparison

Figure 39:A comparison of the SERS spectrum of JWH-018 N-pentanoic acid metabolite
as the pure drug and in a spiked urine sample after µ-SPE.
Hey
6.3.12
JWH-018 N-(5-hydroxypentyl) metabolite pure drug and extraction comparison

Figure 40: A comparison of the SERS spectrum of JWH-018 N-(5-hydroxypentyl)
metabolite as the pure drug and in a spiked urine sample after µ-SPE.
7. CONCLUSIONS AND FUTURE WORK
This work shows the development of a rapid screening technique for the detection
of trace levels of synthetic cannabinoid parent compounds and two JWH-018 metabolites.
Initially, four synthetic cannabinoid parent compounds (JWH-018, JWH-0073, JWH-081
and JWH-122) were analyzed via previously developed SERS method for the detection of

100

trace levels of benzodiazepines. To the author’s knowledge, this was the first paper
published on use of SERS to detect synthetic cannabinoids in solution.
The SERS method involved the use of a gold nanoparticle solution with the
addition of an aggregating agent to detect the synthetic cannabinoids. The aggregating
agents examined included chloride, sulfate, and nitrate salts ranging from 0.00835M –
0.0334 M. The initial study with the benchtop Raman spectrometer concluded that
0.0167M MgCl2 produced the lowest LODs ranging between 18 - 60 ng/mL and that each
synthetic cannabinoid produced a spectrum that was different from each other.
In addition to the optimization of the SERS method, the study compared the use
of a portable and benchtop Raman spectrometer. The SERS spectrums produced from
each instrument was compared to Raman spectrum of the powder form of the drug. The
results showed that JWH-018 and JWH-073 produced a SERS spectrum that was
different between the benchtop and portable instrument as well as the Rama spectrum of
the powder form of the drug. However, JWH-081 and JWH-122 produced SERS
spectrums that were similar to each other and to the Raman spectrum of the standard.
When comparing the LODs, the results concluded that the portable spectrometer can
produce LODs similar to that of the benchtop spectrometer. However, a higher MgCl2
concentrated was needed for 3 out of 4 synthetic cannabinoids examined to produce
similar LODs. Overall the study concluded, that SERS could be used to detect synthetic
cannabinoids at low levels and that a cheaper instrument could be used to produce similar
results but require modification to the SERS method.
To determine if a SERS method has been optimized, various synthetic
cannabinoids and a wide range of aggregating agents need to be examined. The second
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study expanded to examining nine synthetic cannabinoid parent compounds and assessed
the use of monovalent, divalent, and trivalent salts as aggregating agents. In SERS, the
aggregating agent is used to destabilize the gold nanoparticles in solution creating ‘hot
spots’ where the Raman signal is enhanced.
Gaining an understanding of the gold nanoparticle and aggregating agent
interaction is important in the development of an optimized SERS method. Therefore, a
study was conducted analyzing the effect of various salts. Initially, either 0.84M
monovalent salts or 0.05M monovalent or divalent salts were titrated in 10 µL increments
to the gold nanoparticle solution to assess the color change (red to purple to grey/clear)
and change in the absorbance of the nanoparticle solution via UV-VIS spectroscopy. As
the aggregating agent concentration increased, the UV-VIS spectrum produced a decrease
in the absorbance and a red shift in the UV-VIS spectrum from 521 nm to a higher
wavelength, which occurred for all the salts examined. Yet, the salt concentration varied
at which this transition occurred. A higher salt concentration was needed for monovalent
salts compared to divalent and trivalent salts to produce the same effect; however, no
significant difference was observed comparing the various anions. This showed that the
aggregating agent cation can influence nanoparticle aggregation.
For the second part of the aggregating agent study, the effect on nanoparticle size
and zeta potential was examined for each salt at the three concentrations: initial salt
concentration added as well as the salt concentrations at which the nanoparticle solution
turned purple and grey. For the nanoparticle size study, as the salt was added to the
nanoparticle solution, a single peak distribution, seen in stabilized gold nanoparticles,
formed two unresolved peak distributions. At the purple color transition, the two peaks
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become more resolved showing the amount of aggregated versus unaggregated
nanoparticles. At the grey/clear color transition, a single resolved peak was formed
showing that all nanoparticles in solution have aggregated.
For the zeta potential study, upon the addition of the aggregating agent the zeta
potential of the nanoparticle solution decreased. As the concentration of the aggregating
agent increased, the zeta potential further decreased. This was to be expected. Stabilized
nanoparticles have a higher zeta potential value than the recorded average nanoparticle
size. Destabilization occurs when the recorded zeta potential is a lower value than the
average nanoparticle size. The results both studies were seen for all the aggregating
agents examined. While the previous studies only focused on the effects of monovalent
cationic salts on aggregation, this study focused on the effects of monovalent, divalent,
and trivalent cationic salts. The results obtained for all the salts examined results agree
with the Schulze–Hardy rule. The higher the valence of the aggregating agent cation,
Al3+, the least amount of salt needed to produce the CCC for gold nanoparticles.
After gaining an understanding of the aggregating agent and gold nanoparticle
interaction, nine different synthetic cannabinoids were examined using the various salts at
the determined CCC. Out of all the salts examined, 0.0015 MgCl2 was the optimal
aggregating agent with limits of detection (LOD) ranging from 20 to 130 ng/mL. These
LODs agree with initial study. Therefore, showing that a lower MgCl2 concentration can
be used to produce similar results.
The final portions of this study fused on the practical application of the developed
SERS method to detect synthetic cannabinoid metabolites in spiked urine samples. The
parent compounds were not analyzed in this study because they are not likely to be found
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in urine samples. Initially, the optimized SERS method developed in chapter 4 was used
to detect two JWH-018 metabolite standards in a 10% MeOH solution producing an LOD
as low as 37 ng/mL. This showed that both parent compounds and metabolites of
synthetic cannabinoids could be detected using this SERS method. Then, urine samples
spiked with the JWH-018 metabolites at various concentrations were examined using
SLE or µ-SPE as the extraction method. Despite varying the urine sample pretreatments
and the addition of acidic MeOH after the extraction, no variation of the SLE method
produced a SERS spectrum that was different to that of the negative control. However,
the SERS spectrum of the JWH-018 metabolites could be produced using µ-SPE with a
LOD as low as 650 ng/mL.
Further study needs to be conducted to optimize the µ-SPE method examined in
this study to obtain a LOD similar to the results achieved in chapter 4. Adjusting the pH
of the urine sample prior to being washed with the ZipTip pipette tip could help with the
extraction. An adjustment of the ratio of nanoparticles to aggregating agent to drug need
to be examined. The optimized method in chapter 4 has a 1:100 dilution of the drug in the
analyzed nanoparticle solution. Therefore, increasing concentration of the analyte of
interest, could increase the recovery of the sample after the extraction and lower the
LOD.
Another factor to consider is how to gain a better understanding of the success of
the method. It is done by calculating the LOD. In the chapters examined in my study, the
LOD was calculated using a single peak in the SERS spectrum using a specific dynamic
range in which a linear fit was optimal for the parent compounds and a logarithmic fit
was optimal for the JWH-018 metabolites. Further study can be conducted on using a
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ratio of the Raman signal intensity of multiple peaks in the SERS spectrum. A recent
study showed that using a ratio of the Raman signal intensity at two peaks in the SERS
spectrum provided a better curve fit to the wide concentration range examined. Instead of
a linear fit, a Langmuir adsorption curve was seen.87
Once an optimized extraction method has been developed, additional synthetic
cannabinoid metabolites need to be examined as well as metabolites of cathinones and
opioids. If the above compounds can be detected using this optimized SERS method, then
further studies need to be conducted on additional biological matrixes such as oral fluid
and blood. Our research group was able to detect JWH-018 in spiked oral fluid samples at
a LOD of 0.8 ng/mL.87 Additional compounds need to be examined in oral fluid samples.
If this developed SERS method with gold nanoparticles cannot be used to detect all the
above-mentioned compounds, then the next step will be to examine other nanoparticles of
various shapes and metal composition.
Raman spectroscopy provides spectrum that can be used to interpret unknown
compounds that could give a false negative if tested via an immunoassay. Overall the
SERS method has demonstrated that synthetic cannabinoids can be detected at
concentrations as low as 20 ng/mL.
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